{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:23:30Z","timestamp":1792808610518,"version":"4.5.0"},"reference-count":355,"publisher":"Japanese Circulation Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2019,10,25]]},"DOI":"10.1253\/circj.cj-19-0508","type":"journal-article","created":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T18:03:23Z","timestamp":1570557803000},"page":"2329-2388","source":"Crossref","is-referenced-by-count":466,"title":["JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis\u3000\u2015 Digest Version \u2015"],"prefix":"10.1253","volume":"83","author":[{"given":"Fumio","family":"Terasaki","sequence":"first","affiliation":[{"name":"Medical Education Center \/ Department of Cardiology, Osaka Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arata","family":"Azuma","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihisa","family":"Anzai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobukazu","family":"Ishizaka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (III) \/ Department of Cardiology, Osaka Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kaizuka City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuaki","family":"Isobe","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical and Dental Science, Tokyo Medical and Dental University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Inomata","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kitasato University Kitasato Institute Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatsue","family":"Ishibashi-Ueda","sequence":"additional","affiliation":[{"name":"Department of Pathology and Biobank, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Eishi","sequence":"additional","affiliation":[{"name":"Department of Human Pathology, Graduate School of Medical and Dental Science, Tokyo Medical and Dental University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kitakaze","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Development, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Kusano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Sakata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriharu","family":"Shijubo","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, JR Sapporo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Tsuchida","sequence":"additional","affiliation":[{"name":"Department of Cardiology, JR Sapporo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tsutsui","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatomo","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Saitama Cardiovascular and Respiratory Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nakatani","sequence":"additional","affiliation":[{"name":"Division of Functional Diagnostics, Department of Health Sciences, Osaka University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiko","family":"Horii","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Kagawa University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Yazaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Saku Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuro","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Allergology, Aichi Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Shinjuku Kaijou Building Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Ide","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Okamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuchika","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fujita Health University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Goya","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical and Dental University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Sakakibara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Soejima","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kyorin University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Hiroshima-Nishi Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Noda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Osaka Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Ohe","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sakakibara Heart Institute of Okayama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuki","family":"Kihara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Cardiorenal Medicine and Metabolic Disease, Nara Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiko","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichiro","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fujita Health University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yamashina","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Japanese Circulation Society Joint Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. \u3000Yazaki Y, Isobe M, Hiramitsu S, et al. Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Am J Cardiol<\/i> 1998; 82: 537\u2013540. PMID: 9723651","DOI":"10.1016\/S0002-9149(98)00377-4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. \u3000Otsuka K, Terasaki F, Eishi Y, et al. Cardiac sarcoidosis underlies idiopathic dilated cardiomyopathy: Importance of mediastinal lymphadenopathy in differential diagnosis. Circ J<\/i> 2007; 71: 1937\u20131941. PMID: 18037750","DOI":"10.1253\/circj.71.1937"},{"key":"3","unstructured":"3. \u3000Terasaki F, Kitaura Y. Current status of cardiac sarcoidosis with dilated cardiomyopathy - with special reference to patients who underwent left ventriculoplasty (Batista operation). The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders<\/i> 2004; 24: 21\u201330. [In Japanese]"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. \u3000Okura Y, Dec GW, Hare JM, et al. A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol<\/i> 2003; 41: 322\u2013329 PMID: 125358295.","DOI":"10.1016\/S0735-1097(02)02715-8"},{"key":"5","unstructured":"5. \u3000Hiraga Y, Iwai K, Hiroe M, et al. Guidelines for the diagnosis of cardiac sarcoidosis 1992 - Preparation process. The 1993 report of the MHLW-funded study group on diffuse pulmonary diseases; 23\u201324. [In Japanese]"},{"key":"6","unstructured":"6. \u3000The Japan Society of Sarcoidosis and Other Granulomatous Disorders, the Diffuse Pulmonary Study Group of the Health and Labor Sciences Research Grant-supported Rare\/Intractable Disease Project, et al. Committee for revision of the diagnostic standard for sarcoidosis. Diagnostic standard and guideline for sarcoidosis - 2006. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders<\/i> 2007; 27: 89\u2013102. [In Japanese]"},{"key":"7","unstructured":"7. \u3000The Japanese Circulation Society. Guidelines for diagnosis and treatment of myocarditis (JCS 2009). http:\/\/www.j-circ.or.jp\/guideline\/pdf\/JCS2009_izumi_h.pdf [In Japanese]"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. \u3000JCS Joint Working Group. Guidelines for diagnosis and treatment of myocarditis (JCS 2009): Digest version. Circ J<\/i> 2011; 75: 734\u2013743.","DOI":"10.1253\/circj.CJ-88-0008"},{"key":"9","unstructured":"9. \u3000The Japan Society of Sarcoidosis and Other Granulomatous Disorders, the Japanese Respiratory Society, the Japanese College of Cardiology, et al. Sarcoidosis Treatment Guideline Preparation Committee. Views on the treatment of sarcoidosis - 2003. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders<\/i> 2003; 23: 105\u2013114. [In Japanese]"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. \u3000American Thoracic Society (ATS), the European Respiratory Society (ERS), the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG). Statement on sarcoidosis. Am J Respir Crit Care Med<\/i> 1999; 160: 736\u2013755. PMID: 10430755","DOI":"10.1164\/ajrccm.160.2.ats4-99"},{"key":"11","unstructured":"11. \u3000Milman N, Selroos O. Pulmonary sarcoidosis in the Nordic countries 1950\u20131982: Epidemiology and clinical picture. Sarcoidosis<\/i> 1990; 7: 50\u201357. PMID: 2345819"},{"key":"12","unstructured":"12. \u3000Iwai K, Sekiguti M, Hosoda Y, et al. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis<\/i> 1994; 11: 26\u201331. PMID: 8036339"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. \u3000Sawahata M, Sugiyama Y, Nakamura Y, et al. Age-related and historical changes in the clinical characteristics of sarcoidosis in Japan. Respir Med<\/i> 2015; 109: 272\u2013278. PMID: 25613109","DOI":"10.1016\/j.rmed.2014.12.012"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. \u3000Henke CE, Henke G, Elveback LR, et al. The epidemiology of sarcoidosis in Rochester, Minnesota: A population-based study of incidence and survival. Am J Epidemiol<\/i> 1986; 123: 840\u2013845. PMID: 3962966","DOI":"10.1093\/oxfordjournals.aje.a114313"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. \u3000Rybicki BA, Major M, Popovich J Jr, et al. Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization. Am J Epidemiol<\/i> 1997; 145: 234\u2013241. PMID: 9012596","DOI":"10.1093\/oxfordjournals.aje.a009096"},{"key":"16","unstructured":"16. \u3000Morimoto Y, Azuma A, Abe S, et al. Epidemiology of sarcoidosis in Japan. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders<\/i> 2007; 27: 103\u2013108. [In Japanese]"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. \u3000Iwai K, Tachibana T, Takemura T, et al. Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn<\/i> 1993; 43: 372\u2013376. PMID: 8372682","DOI":"10.1111\/j.1440-1827.1993.tb01148.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. \u3000Matsui Y, Iwai K, Tachibana T, et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci<\/i> 1976; 278: 455\u2013469. PMID: 1067031","DOI":"10.1111\/j.1749-6632.1976.tb47058.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. \u3000Iwai K, Takemura T, Kitaichi M, et al. Pathological studies on sarcoidosis autopsy. II. Early change, mode of progression and death pattern. Acta Pathol Jpn<\/i> 1993; 43: 377\u2013385. PMID: 8372683","DOI":"10.1111\/j.1440-1827.1993.tb01149.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. \u3000Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation<\/i> 1978; 58: 1204\u20131211. PMID: 709777","DOI":"10.1161\/01.CIR.58.6.1204"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. \u3000Yazaki Y, Isobe M, Hiroe M, et al. Central Japan Heart Study Group. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol<\/i> 2001; 88: 1006\u20131010. PMID: 11703997","DOI":"10.1016\/S0002-9149(01)01978-6"},{"key":"22","unstructured":"22. \u3000Homma JY, Abe C, Chosa H, et al. Bacteriological investigation on biopsy specimens from patients with sarcoidosis. Jpn J Exp Med<\/i> 1978; 48: 251\u2013255. PMID: 713130"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. \u3000Eishi Y, Suga M, Ishige I, et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol<\/i> 2002; 40: 198\u2013204. PMID: 11773116","DOI":"10.1128\/JCM.40.1.198-204.2002"},{"key":"24","unstructured":"24. \u3000Minami J, Eishi Y, Ishige Y, et al. Pulmonary granulomas caused experimentally in mice by a recombinant trigger-factor protein of Propionibacterium acnes<\/i>. J Med Dent Sci<\/i> 2003; 50: 265\u2013274. PMID: 15074354"},{"key":"25","unstructured":"25. \u3000Hiraga Y, Hashimoto T, Saito N, et al. Double-blind comparative study on antibiotic (L-Keflex) in sarcoidosis. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders<\/i> 1987; 7: 103\u2013105. [In Japanese]"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. \u3000Harada K, Tsuneyama K, Sudo Y, et al. Molecular identification of bacterial 16S ribosomal RNA gene in liver tissue of primary biliary cirrhosis: Is Propionibacterium acnes<\/i> involved in granuloma formation? Hepatology<\/i> 2001; 33: 530\u2013536. PMID: 11230731","DOI":"10.1053\/jhep.2001.22653"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. \u3000Song Z, Marzilli L, Greenlee BM, et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med<\/i> 2005; 201: 755\u2013767. PMID: 15753209","DOI":"10.1084\/jem.20040429"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. \u3000Chen ES, Moller DR. Etiologies of Sarcoidosis. Clin Rev Allergy Immunol<\/i> 2015; 49: 6\u201318. PMID: 25771769","DOI":"10.1007\/s12016-015-8481-z"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. \u3000Inui N, Suda T, Chida K. Use of the QuantiFERON-TB Gold test in Japanese patients with sarcoidosis. Respir Med<\/i> 2008; 102: 313\u2013315. PMID: 17980570","DOI":"10.1016\/j.rmed.2007.09.013"},{"key":"30","unstructured":"30. \u3000Kataoka M, Nakata Y, Hiramatsu J, et al. Familial occurrence of sarcoidosis in Japan and analysis of genetic influence. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders<\/i> 2000; 20: 21\u201326. [In Japanese]"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. \u3000Rybicki BA, Iannuzzi MC, Frederick MM, et al. ACCESS Research Group. Familial aggregation of sarcoidosis: A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med<\/i> 2001; 164: 2085\u20132091. PMID: 11739139","DOI":"10.1164\/ajrccm.164.11.2106001"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. \u3000Ishihara M, Ohno S, Ishida T, et al. Molecular genetic studies of HLA class II alleles in sarcoidosis. Tissue Antigens<\/i> 1994; 43: 238\u2013241. PMID: 8085259","DOI":"10.1111\/j.1399-0039.1994.tb02331.x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. \u3000Foley PJ, McGrath DS, Puscinska E, et al. Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. Am J Respir Cell Mol Biol<\/i> 2001; 25: 272\u2013277. PMID: 11588003","DOI":"10.1165\/ajrcmb.25.3.4261"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. \u3000Spagnolo P, Sato H, Grutters JC, et al. Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis. Tissue Antigens<\/i> 2007; 70: 219\u2013227. PMID: 17661910","DOI":"10.1111\/j.1399-0039.2007.00879.x"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. \u3000Berlin M, Fogdell-Hahn A, Olerup O, et al. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med<\/i> 1997; 156: 1601\u20131605. PMID: 9372682","DOI":"10.1164\/ajrccm.156.5.9704069"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. \u3000Hizawa N, Yamaguchi E, Furuya K, et al. The role of the C-C chemokine receptor 2 gene polymorphism V64I (CCR2-64I) in sarcoidosis in a Japanese population. Am J Respir Crit Care Med<\/i> 1999; 159: 2021\u20132023. PMID: 10351956","DOI":"10.1164\/ajrccm.159.6.9810020"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. \u3000Tanabe T, Ishige I, Suzuki Y, et al. Sarcoidosis and NOD1 variation with impaired recognition of intracellular Propionibacterium acnes<\/i>. Biochim Biophys Acta<\/i> 2006; 1762: 794\u2013801. PMID: 16935475","DOI":"10.1016\/j.bbadis.2006.07.006"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. \u3000Valentonyte R, Hampe J, Huse K, et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2<\/i>. Nat Genet<\/i> 2005; 37: 357\u2013364. PMID: 15735647","DOI":"10.1038\/ng1519"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. \u3000Rybicki BA, Maliarik MJ, Poisson LM, et al. Sarcoidosis and granuloma genes: A family-based study in African-Americans. Eur Respir J<\/i> 2004; 24: 251\u2013257. PMID: 15332393","DOI":"10.1183\/09031936.04.00005904"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. \u3000Hofmann S, Franke A, Fischer A, et al. Genome-wide association study identifies ANXA11<\/i> as a new susceptibility locus for sarcoidosis. Nat Genet<\/i> 2008; 40: 1103\u20131106. PMID: 19165924","DOI":"10.1038\/ng.198"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. \u3000Hofmann S, Fischer A, Till A, et al. GenPhenReSa Consortium. A genome-wide association study reveals evidence of association with sarcoidosis at 6p12.1. Eur Respir J<\/i> 2011; 38: 1127\u20131135. PMID: 21540310","DOI":"10.1183\/09031936.00001711"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. \u3000Fischer A, Schmid B, Ellinghaus D, et al. A novel sarcoidosis risk locus for Europeans on chromosome 11q13.1. Am J Respir Crit Care Med<\/i> 2012; 186: 877\u2013885. PMID: 22837380","DOI":"10.1164\/rccm.201204-0708OC"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. \u3000Hofmann S, Fischer A, Nothnagel M, et al. Genome-wide association analysis reveals 12q13.3-q14.1 as new risk locus for sarcoidosis. Eur Respir J<\/i> 2013; 41: 888\u2013900. PMID: 22936702","DOI":"10.1183\/09031936.00033812"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. \u3000Levin AM, Iannuzzi MC, Montgomery CG, et al. Admixture fine-mapping in African Americans implicates XAF1<\/i> as a possible sarcoidosis risk gene. PLoS One<\/i> 2014; 9: e92646. PMID: 24663488","DOI":"10.1371\/journal.pone.0092646"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. \u3000Kodama N, Yamaguchi E, Hizawa N, et al. Expression of RANTES by bronchoalveolar lavage cells in nonsmoking patients with interstitial lung diseases. Am J Respir Cell Mol Biol<\/i> 1998; 18: 526\u2013531. PMID: 9533940","DOI":"10.1165\/ajrcmb.18.4.2868"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. \u3000Yamaguchi E, Okazaki N, Tsuneta Y, et al. Interleukins in pulmonary sarcoidosis. Dissociative correlations of lung interleukins 1 and 2 with the intensity of alveolitis. Am Rev Respir Dis<\/i> 1988; 138: 645\u2013651. PMID: 3264477","DOI":"10.1164\/ajrccm\/138.3.645"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. \u3000Yamaguchi E, Itoh A, Furuya K, et al. Release of tumor necrosis factor-alpha from human alveolar macrophages is decreased in smokers. Chest<\/i> 1993; 103: 479\u2013483. PMID: 8432140","DOI":"10.1378\/chest.103.2.479"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. \u3000Itoh A, Yamaguchi E, Kuzumaki N, et al. Expression of granulocyte-macrophage colony-stimulating factor mRNA by inflammatory cells in the sarcoid lung. Am J Respir Cell Mol Biol<\/i> 1990; 3: 245\u2013249. PMID: 2202340","DOI":"10.1165\/ajrcmb\/3.3.245"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. \u3000Robinson BW, McLemore TL, Crystal RG. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest<\/i> 1985; 75: 1488\u20131495. PMID: 3923038","DOI":"10.1172\/JCI111852"},{"key":"50","unstructured":"50. \u3000Hancock WW, Kobzik L, Colby AJ, et al. Detection of lymphokines and lymphokine receptors in pulmonary sarcoidosis. Immunohistologic evidence that inflammatory macrophages express IL-2 receptors. Am J Pathol<\/i> 1986; 123: 1\u20138. PMID: 3083688"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. \u3000Shigehara K, Shijubo N, Ohmichi M, et al. Increased circulating interleukin-12 (IL-12) p40 in pulmonary sarcoidosis. Clin Exp Immunol<\/i> 2003; 132: 152\u2013157. PMID: 12653850","DOI":"10.1046\/j.1365-2249.2003.02105.x"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. \u3000Tanaka H, Miyazaki N, Oashi K, et al. IL-18 might reflect disease activity in mild and moderate asthma exacerbation. J Allergy Clin Immunol<\/i> 2001; 107: 331\u2013336. PMID: 11174201","DOI":"10.1067\/mai.2001.112275"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. \u3000Agostini C, Cassatella M, Zambello R, et al. Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. J Immunol<\/i> 1998; 161: 6413\u20136420. PMID: 9834133","DOI":"10.4049\/jimmunol.161.11.6413"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. \u3000Ten Berge B, Paats MS, Bergen IM, et al. Increased IL-17A expression in granulomas and in circulating memory T cells in sarcoidosis. Rheumatology (Oxford)<\/i> 2012; 51: 37\u201346. PMID: 22075064","DOI":"10.1093\/rheumatology\/ker316"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. \u3000Furusawa H, Suzuki Y, Miyazaki Y, et al. Th1 and Th17 immune responses to viable Propionibacterium acnes<\/i> in patients with sarcoidosis. Respir Investig<\/i> 2012; 50: 104\u2013109. PMID: 23021769","DOI":"10.1016\/j.resinv.2012.07.001"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. \u3000Saussine A, Tazi A, Feuillet S, et al. Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels. PLoS One<\/i> 2012; 7: e43588. PMID: 22927996","DOI":"10.1371\/journal.pone.0043588"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. \u3000Homma S, Nagaoka I, Abe H, et al. Localization of platelet-derived growth factor and insulin-like growth factor I in the fibrotic lung. Am J Respir Crit Care Med<\/i> 1995; 152: 2084\u20132089. PMID: 8520779","DOI":"10.1164\/ajrccm.152.6.8520779"},{"key":"58","unstructured":"58. \u3000Ishioka S, Saito T, Hiyama K, et al. Increased expression of tumor necrosis factor-alpha, interleukin-6, platelet-derived growth factor-B and granulocyte-macrophage colony-stimulating factor mRNA in cells of bronchoalveolar lavage fluids from patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis<\/i> 1996; 13: 139\u2013145. PMID: 8893383"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. \u3000Allen JT, Knight RA, Bloor CA, et al. Enhanced insulin-like growth factor binding protein-related protein 2 (Connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Cell Mol Biol<\/i> 1999; 21: 693\u2013700. PMID: 10572066","DOI":"10.1165\/ajrcmb.21.6.3719"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. \u3000Abe C, Iwai K, Mikami R, et al. Frequent isolation of Propionibacterium acnes<\/i> from sarcoidosis lymph nodes. Zentralbl Bakteriol Mikrobiol Hyg A<\/i> 1984; 256: 541\u2013547. PMID: 6377763","DOI":"10.1016\/S0174-3031(84)80032-3"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. \u3000Ishige I, Usui Y, Takemura T, et al. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet<\/i> 1999; 354: 120\u2013123. PMID: 10408488","DOI":"10.1016\/S0140-6736(98)12310-3"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. \u3000Yamada T, Eishi Y, Ikeda S, et al. In situ<\/i> localization of Propionibacterium acnes<\/i> DNA in lymph nodes from sarcoidosis patients by signal amplification with catalysed reporter deposition. J Pathol<\/i> 2002; 198: 541\u2013547. PMID: 12434425","DOI":"10.1002\/path.1243"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. \u3000Negi M, Takemura T, Guzman J, et al. Localization of Propionibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium. Mod Pathol<\/i> 2012; 25: 1284\u20131297. PMID: 22596102","DOI":"10.1038\/modpathol.2012.80"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. \u3000Eishi Y. Etiologic aspect of sarcoidosis as an allergic endogenous infection caused by Propionibacterium acnes<\/i>. Biomed Res Int<\/i> 2013; 2013: 935289. PMID: 23844371","DOI":"10.1155\/2013\/935289"},{"key":"65","unstructured":"65. \u3000MHW-funded study group on diffuse pulmonary diseases. Sarcoidosis. Diagnosis and treatment strategies for rare\/intractable diseases (Supervised by the Disease Control Division, the Health Service Bureau, the Ministry of Health and Welfare). 1997; 62\u201365. [In Japanese]"},{"key":"66","unstructured":"66. \u3000MHLW-funded study group on diffuse pulmonary diseases. Sarcoidosis. Textbook for rare\/intractable disease specialist (Supervised by the Disease Control Division, the Health Service Bureau, the Ministry of Health, Labour and Welfare). 2015. [In Japanese]"},{"key":"67","unstructured":"67. \u3000The Japan Society of Sarcoidosis and Other Granulomatous Disorders. Diagnostic standard and guideline for sarcoidosis \u2013 2015. http:\/\/www.jssog.com\/www\/top\/shindan\/shindan2-1new.html [In Japanese]"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. \u3000Baughman RP, Teirstein AS, Judson MA, et al. Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med<\/i> 2001; 164: 1885\u20131889. PMID: 11734441","DOI":"10.1164\/ajrccm.164.10.2104046"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. \u3000Baughman RP. Pulmonary sarcoidosis. Clin Chest Med<\/i> 2004; 25: 521\u2013530, vi. PMID: 15331189","DOI":"10.1016\/j.ccm.2004.04.006"},{"key":"70","unstructured":"70. \u3000King TE Jr. Clinical manifestations and diagnosis of pulmonary sarcoidosis. UpToDate 2016. http:\/\/www.uptodate.com\/contents\/clinical-manifestations-and-diagnosis-of-pulmonary-sarcoidosis"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. \u3000Fujimoto K. Thoracic diagnostic imaging of sarcoidosis. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders<\/i> 2013; 33: 31\u201334. [In Japanese]","DOI":"10.7878\/jjsogd.33.31"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. \u3000Hours S, Nunes H, Kambouchner M, et al. Pulmonary cavitary sarcoidosis: Clinico-radiologic characteristics and natural history of a rare form of sarcoidosis. Medicine (Baltimore)<\/i> 2008; 87: 142\u2013151. PMID: 18520323","DOI":"10.1097\/MD.0b013e3181775a73"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. \u3000Koyama T, Ueda H, Togashi K, et al. Radiologic manifestations of sarcoidosis in various organs. Radiographics<\/i> 2004; 24: 87\u2013104. PMID: 14730039","DOI":"10.1148\/rg.241035076"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. \u3000Malaisamy S, Dalal B, Bimenyuy C, et al. The clinical and radiologic features of nodular pulmonary sarcoidosis. Lung<\/i> 2009; 187: 9\u201315. PMID: 18843518","DOI":"10.1007\/s00408-008-9118-2"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. \u3000Sileo C, Epaud R, Mahloul M, et al. Sarcoidosis in children: HRCT findings and correlation with pulmonary function tests. Pediatr Pulmonol<\/i> 2014; 49: 1223\u20131233. PMID: 24339447","DOI":"10.1002\/ppul.22956"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. \u3000Paramothayan NS, Lasserson TJ, Jones PW. Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst Rev<\/i> 2005; CD001114. PMID: 15846612","DOI":"10.1002\/14651858.CD001114.pub2"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. \u3000Gibson GJ, Prescott RJ, Muers MF, et al. British Thoracic Society Sarcoidosis study: Effects of long term corticosteroid treatment. Thorax<\/i> 1996; 51: 238\u2013247. PMID: 8779124","DOI":"10.1136\/thx.51.3.238"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. \u3000Pietinalho A, Tukiainen P, Haahtela T, et al. Finnish Pulmonary Sarcoidosis Study Group. Early treatment of stage II sarcoidosis improves 5-year pulmonary function. Chest<\/i> 2002; 121: 24\u201331. PMID: 11796428","DOI":"10.1378\/chest.121.1.24"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. \u3000Miller A. Of time and experience: Sarcoidosis revisited. Chest<\/i> 2002; 121: 3\u20135. PMID: 11796421","DOI":"10.1378\/chest.121.1.3"},{"key":"80","unstructured":"80. \u3000Izumi T. Are corticosteroids harmful to sarcoidosis: A conclusion drawn from a retrospective study on the chest radiographic prognosis of 185 asymptomatic patients with pulmonary sarcoidosis followed up for more than 10 years. Sarcoidosis<\/i> 1994; 11(Suppl 1): 119\u2013122."},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. \u3000Gottlieb JE, Israel HL, Steiner RM, et al. Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy. Chest<\/i> 1997; 111: 623\u2013631. PMID: 9118698","DOI":"10.1378\/chest.111.3.623"},{"key":"82","unstructured":"82. \u3000Rizzato G, Montemurro L, Colombo P. The late follow-up of chronic sarcoid patients previously treated with corticosteroids. Sarcoidosis Vasc Diffuse Lung Dis<\/i> 1998; 15: 52\u201358. PMID: 9572002"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83. \u3000Baughman RP, Culver DA, Judson MA. A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med<\/i> 2011; 183: 573\u2013581. PMID: 21037016","DOI":"10.1164\/rccm.201006-0865CI"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84. \u3000Johns CJ, Michele TM. The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital. Medicine (Baltimore)<\/i> 1999; 78: 65\u2013111. PMID: 10195091","DOI":"10.1097\/00005792-199903000-00001"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85. \u3000Judson MA. The treatment of pulmonary sarcoidosis. Respir Med<\/i> 2012; 106: 1351\u20131361. PMID: 22495110","DOI":"10.1016\/j.rmed.2012.01.013"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86. \u3000Shijubo N, Ito M, Ichimura S, et al. A case of pulmonary sarcoidosis with bronchovascular bundle lesions and cavity improved with low dose corticosteroid therapy. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders<\/i> 2013; 33: 123\u2013126. [In Japanese]","DOI":"10.7878\/jjsogd.33.123"},{"key":"87","unstructured":"87. \u3000Kato Y, Morimoto S, Uemura A, et al. Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block. Sarcoidosis Vasc Diffuse Lung Dis<\/i> 2003; 20: 133\u2013137. PMID: 12870723"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88. \u3000Cremers JP, Drent M, Bast A, et al. Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: Integrating systematic literature research and expert opinion of sarcoidologists worldwide. Curr Opin Pulm Med<\/i> 2013; 19: 545\u2013561. PMID: 23880702","DOI":"10.1097\/MCP.0b013e3283642a7a"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89. \u3000Vorselaars AD, Wuyts WA, Vorselaars VM, et al. Methotrexate vs azathioprine in second-line therapy of sarcoidosis. Chest<\/i> 2013; 144: 805\u2013812. PMID: 23538719","DOI":"10.1378\/chest.12-1728"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90. \u3000Nagai S, Yokomatsu T, Tanizawa K, et al. Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions. Intern Med<\/i> 2014; 53: 427\u2013433. PMID: 24583430","DOI":"10.2169\/internalmedicine.53.0794"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91. \u3000Isshiki T, Yamaguchi T, Yamada Y, et al. Usefulness of low-dose methotrexate monotherapy for treating sarcoidosis. Intern Med<\/i> 2013; 52: 2727\u20132732. PMID: 24334575","DOI":"10.2169\/internalmedicine.52.0976"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92. \u3000Bachelez H, Senet P, Cadranel J, et al. The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol<\/i> 2001; 137: 69\u201373. PMID: 11176663","DOI":"10.1001\/archderm.137.1.69"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93. \u3000Yamaguchi T, Yamaguchi Y, Suzuki M, et al. Treatment of sarcoidosis by the use of doxycycline. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders<\/i> 2014; 34: 31\u201333. [In Japanese]","DOI":"10.7878\/jjsogd.34.31"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94. \u3000Michielsen HJ, Drent M, Peros-Golubicic T, et al. Fatigue is associated with quality of life in sarcoidosis patients. Chest<\/i> 2006; 130: 989\u2013994. PMID: 17035429","DOI":"10.1378\/chest.130.4.989"},{"key":"95","unstructured":"95. \u3000Hoitsma E, De Vries J, van Santen-Hoeufft M, et al. Impact of pain in a Dutch sarcoidosis patient population. Sarcoidosis Vasc Diffuse Lung Dis<\/i> 2003; 20: 33\u201339. PMID: 12737278"},{"key":"96","unstructured":"96. \u3000Murai M, Yamaguchi T, Mitsuma T, et al. A case of sarcoidosis accompanying systemic symptoms successfully treated with kampo medications. Annals of the Japanese Respiratory Society<\/i> 2012; 1: 9\u201313. [In Japanese]"},{"key":"97","doi-asserted-by":"crossref","unstructured":"97. \u3000Saito H, Yamaguchi T, Adachi Y, et al. Neurological symptoms of sarcoidosis-induced small fiber neuropathy effectively relieved with high-dose steroid pulse therapy. Intern Med<\/i> 2015; 54: 1281\u20131286. PMID: 25986271","DOI":"10.2169\/internalmedicine.54.3702"},{"key":"98","doi-asserted-by":"crossref","unstructured":"98. \u3000Yoshida Y, Morimoto S, Hiramitsu S, et al. Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block. Am Heart J<\/i> 1997; 134: 382\u2013386. PMID: 9327691","DOI":"10.1016\/S0002-8703(97)70070-X"},{"key":"99","doi-asserted-by":"crossref","unstructured":"99. \u3000Uemura A, Morimoto S, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: Evaluation of endomyocardial biopsies. Am Heart J<\/i> 1999; 138: 299\u2013302. PMID: 10426842","DOI":"10.1016\/S0002-8703(99)70115-8"},{"key":"100","doi-asserted-by":"crossref","unstructured":"100. \u3000From AM, Maleszewski JJ, Rihal CS. Current status of endomyocardial biopsy. Mayo Clin Proc<\/i> 2011; 86: 1095\u20131102. PMID: 22033254","DOI":"10.4065\/mcp.2011.0296"},{"key":"101","doi-asserted-by":"crossref","unstructured":"101. \u3000Valantine H, McKenna WJ, Nihoyannopoulos P, et al. Sarcoidosis: A pattern of clinical and morphological presentation. Br Heart J<\/i> 1987; 57: 256\u2013263. PMID: 3566984","DOI":"10.1136\/hrt.57.3.256"},{"key":"102","doi-asserted-by":"crossref","unstructured":"102. \u3000Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II). Am J Med<\/i> 1977; 63: 86\u2013108. PMID: 327806","DOI":"10.1016\/0002-9343(77)90145-0"},{"key":"103","doi-asserted-by":"crossref","unstructured":"103. \u3000Seward JB, Casaclang-Verzosa G. Infiltrative cardiovascular diseases: Cardiomyopathies that look alike. J Am Coll Cardiol<\/i> 2010; 55: 1769\u20131779. PMID: 20413025","DOI":"10.1016\/j.jacc.2009.12.040"},{"key":"104","doi-asserted-by":"crossref","unstructured":"104. \u3000Lagana SM, Parwani AV, Nichols LC. Cardiac sarcoidosis: A pathology-focused review. Arch Pathol Lab Med<\/i> 2010; 134: 1039\u20131046. PMID: 20586635","DOI":"10.5858\/2009-0274-RA.1"},{"key":"105","doi-asserted-by":"crossref","unstructured":"105. \u3000Blauwet LA, Cooper LT. Idiopathic giant cell myocarditis and cardiac sarcoidosis. Heart Fail Rev<\/i> 2013; 18: 733\u2013746. PMID: 23111533","DOI":"10.1007\/s10741-012-9358-3"},{"key":"106","unstructured":"106. \u3000Ando M, Oritsu M, Kitaichi M, et al. ATS\/ERS\/WASOG statement on sarcoidosis. In: The Japan Society of Sarcoidosis and Other Granulomatous Disorders, editor. Supervised by Ando M and Yotsumoto H. Sarcoidosis and other granulomatous disorders. Kokuseido Shuppan, 2006; 295\u2013329. [In Japanese]"},{"key":"107","doi-asserted-by":"crossref","unstructured":"107. \u3000Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm<\/i> 2014; 11: 1305\u20131323. PMID: 24819193","DOI":"10.1016\/j.hrthm.2014.03.043"},{"key":"108","doi-asserted-by":"crossref","unstructured":"108. \u3000Mehta D, Lubitz SA, Frankel Z, et al. Cardiac involvement in patients with sarcoidosis: Diagnostic and prognostic value of outpatient testing. Chest<\/i> 2008; 133: 1426\u20131435. PMID: 18339784","DOI":"10.1378\/chest.07-2784"},{"key":"109","doi-asserted-by":"crossref","unstructured":"109. \u3000Kato Y, Morimoto S. Analysis of clinical manifestations of cardiac sarcoidosis - A multicentre study: Preliminary report. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders<\/i> 2010; 30: 73\u201376. [In Japanese]","DOI":"10.7878\/jjsogd.30.73"},{"key":"110","unstructured":"110. \u3000Shijubo N, Ichimura S, Ito M, et al. Analysis of several examinations in 516 histologically proven sarcoidosis patients. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders<\/i> 2007; 27: 29\u201335. [In Japanese]"},{"key":"111","unstructured":"111. \u3000Kiyotake R, Okinami S, Soma M, et al. Evaluation of revised diagnosis criteria for sarcoidosis. The Japanese Journal of Dermatology<\/i> 2010; 114: 678\u2013682. [In Japanese]"},{"key":"112","unstructured":"112. \u3000Handa T, Nagai S, Ueda S, et al. Significance of plasma NT-proBNP levels as a biomarker in the assessment of cardiac involvement and pulmonary hypertension in patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis<\/i> 2010; 27: 27\u201335. PMID: 21086902"},{"key":"113","doi-asserted-by":"crossref","unstructured":"113. \u3000Yasutake H, Seino Y, Kashiwagi M, et al. Detection of cardiac sarcoidosis using cardiac markers and myocardial integrated backscatter. Int J Cardiol<\/i> 2005; 102: 259\u2013268. PMID: 15982494","DOI":"10.1016\/j.ijcard.2004.05.028"},{"key":"114","doi-asserted-by":"crossref","unstructured":"114. \u3000Baba Y, Kubo T, Kitaoka H, et al. Usefulness of high-sensitive cardiac troponin T for evaluating the activity of cardiac sarcoidosis. Int Heart J<\/i> 2012; 53: 287\u2013292. PMID: 23038089","DOI":"10.1536\/ihj.53.287"},{"key":"115","doi-asserted-by":"crossref","unstructured":"115. \u3000Tanada Y, Sato Y, Sawa T, et al. Serial measurement of high-sensitivity cardiac troponin I and N-terminal proB-type natriuretic peptide in a patient presenting with cardiac sarcoidosis. Intern Med<\/i> 2012; 51: 3379\u20133381. PMID: 23257523","DOI":"10.2169\/internalmedicine.51.8334"},{"key":"116","doi-asserted-by":"crossref","unstructured":"116. \u3000Kandolin R, Lehtonen J, Airaksinen J, et al. Usefulness of cardiac troponins as markers of early treatment response in cardiac sarcoidosis. Am J Cardiol<\/i> 2015; 116: 960\u2013964. PMID: 26209113","DOI":"10.1016\/j.amjcard.2015.06.021"},{"key":"117","doi-asserted-by":"crossref","unstructured":"117. \u3000Kobayashi S, Myoren T, Oda S, et al. Urinary 8-hydroxy-2\u00b4-deoxyguanosine as a novel biomarker of inflammatory activity in patients with cardiac sarcoidosis. Int J Cardiol<\/i> 2015; 190: 319\u2013328. PMID: 25935620","DOI":"10.1016\/j.ijcard.2015.04.144"},{"key":"118","unstructured":"118. \u3000Semenzato G, Cipriani A, Trentin L, et al. High serum levels of soluble interleukin-2 receptors in sarcoidosis. Sarcoidosis<\/i> 1987; 4: 25\u201327. PMID: 3108983"},{"key":"119","doi-asserted-by":"crossref","unstructured":"119. \u3000Grutters JC, Fellrath JM, Mulder L, et al. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: A clinical evaluation. Chest<\/i> 2003; 124: 186\u2013195. PMID: 12853522","DOI":"10.1378\/chest.124.1.186"},{"key":"120","doi-asserted-by":"crossref","unstructured":"120. \u3000Rothkrantz-Kos S, van Dieijen-Visser MP, Mulder PG, et al. Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis. Clin Chem<\/i> 2003; 49: 1510\u20131517. PMID: 12928233","DOI":"10.1373\/49.9.1510"},{"key":"121","unstructured":"121. \u3000Yoshida Y, Morimoto S, Hiramitsu S, et al. Incidence of cardiac sarcoidosis in patients with high-degree atrioventricular block. SHINZO<\/i> 1995; 10: 874\u2013879. [In Japanese]"},{"key":"122","doi-asserted-by":"crossref","unstructured":"122. \u3000Terasaki F, Ukimura A, Tsukada B, et al. Enhanced expression of type 1 helper T-cell cytokines in the myocardium of active cardiac sarcoidosis. Circ J<\/i> 2008; 72: 1303\u20131307. PMID: 18654018","DOI":"10.1253\/circj.72.1303"},{"key":"123","doi-asserted-by":"crossref","unstructured":"123. \u3000Terasaki F, Fujita M, Shimomura H, et al. Enhanced expression of myeloid-related protein complex (MRP8\/14) in macrophages and multinucleated giant cells in granulomas of patients with active cardiac sarcoidosis. Circ J<\/i> 2007; 71: 1545\u20131550. PMID: 17895549","DOI":"10.1253\/circj.71.1545"},{"key":"124","doi-asserted-by":"crossref","unstructured":"124. \u3000Padilla ML. Cardiac sarcoidosis. In: Baughman RP, editor. Sarcoidosis (Lung Biology in Health and Disease vol.210). Taylor & Francis 2006.","DOI":"10.1201\/b13773-25"},{"key":"125","unstructured":"125. \u3000Tsuchida A. Clinical picture of cardiac sarcoidosis. Respiration and Circulation<\/i> 2006; 54: 925\u2013931. [In Japanese]"},{"key":"126","doi-asserted-by":"crossref","unstructured":"126. \u3000Sekhri V, Sanal S, Delorenzo LJ, et al. Cardiac sarcoidosis: A comprehensive review. Arch Med Sci<\/i> 2011; 7: 546\u2013554. PMID: 22291785","DOI":"10.5114\/aoms.2011.24118"},{"key":"127","unstructured":"127. \u3000Oritsu M. Diagnostic criteria and procedures. In: The Japan Society of Sarcoidosis and Other Granulomatous Disorders, editor. Supervised by Ando M and Yotsumoto H. Sarcoidosis and other granulomatous disorders. Kokuseido Shuppan, 2006; 136\u2013143. [In Japanese]"},{"key":"128","unstructured":"128. \u3000Tsuchida A, Nanba M, Endo T, et al. Incidence of cardiac complications in sarcoidosis patients with no abnormalities on electrocardiograms. Circ J<\/i> 2004; 68(Suppl 1): 626."},{"key":"129","unstructured":"129. \u3000Kato Y, Morimoto S, Hiramitsu S, et al. Two cases in which cardiac sarcoidosis was strongly suspected despite not fulfilling the diagnostic guideline. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders<\/i> 1999; 19: 91\u201396. [In Japanese]"},{"key":"130","unstructured":"130. \u3000Tsuchida A, Hasegawa T, Sakamoto J, et al. A case of cardiac sarcoidosis developed ten years after diagnosis of sarcoidosis. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders<\/i> 2008; 28: 81\u201385. [In Japanese]"},{"key":"131","unstructured":"131. \u3000Yazaki Y, Sekiguchi M, Nunoda S, et al. Recent clinical profile of cardiac sarcoidosis cases in Japan. Sarcoidosis<\/i> 1992; 9(Suppl): 399\u2013400."},{"key":"132","unstructured":"132. \u3000Uemura A, Morimoto S. Heart. In: Japan Society of Sarcoidosis and Other Granulomatous Disorders, editor. Ando M, Yotsumoto H, supervisors. Sarcoidosis and other granulomatous disorders. Kokuseido Shuppan, 2006; 72\u201376. [In Japanese]"},{"key":"133","doi-asserted-by":"crossref","unstructured":"133. \u3000Kato Y, Morimoto S. Atrioventricular block in cardiac sarcoidosis. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders<\/i> 2011; 31: 66\u201372. [In Japanese]","DOI":"10.7878\/jjsogd.31.66"},{"key":"134","unstructured":"134. \u3000Morimoto S, Kato Y, Kitakaze M, et al. Clinical picture of sarcoidosis in 134 patients: A multi-center study. J Cardiol<\/i> 2014; (Suppl): O\u2013209. [In Japanese]"},{"key":"135","doi-asserted-by":"crossref","unstructured":"135. \u3000Tsuchida A, Hasegawa T, Sakamoto J, et al. Two cases of cardiac sarcoidosis with complete atrioventricular block naturally improved several years after implanting pacemaker. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders<\/i> 2010; 30: 15\u201320. [In Japanese]","DOI":"10.7878\/jjsogd.30.15"},{"key":"136","doi-asserted-by":"crossref","unstructured":"136. \u3000Kandolin R, Lehtonen J, Graner M, et al. Diagnosing isolated cardiac sarcoidosis. J Intern Med<\/i> 2011; 270: 461\u2013468. PMID: 21535250","DOI":"10.1111\/j.1365-2796.2011.02396.x"},{"key":"137","doi-asserted-by":"crossref","unstructured":"137. \u3000Swanton RH. Sarcoidosis of the heart. Eur Heart J<\/i> 1988; 9 Suppl G: 169\u2013174. PMID: 3042416","DOI":"10.1093\/eurheartj\/9.suppl_G.169"},{"key":"138","doi-asserted-by":"crossref","unstructured":"138. \u3000Furushima H, Chinushi M, Sugiura H, et al. Ventricular tachyarrhythmia associated with cardiac sarcoidosis: Its mechanisms and outcome. Clin Cardiol<\/i> 2004; 27: 217\u2013222. PMID: 15119697","DOI":"10.1002\/clc.4960270409"},{"key":"139","doi-asserted-by":"crossref","unstructured":"139. \u3000Uusimaa P, Ylitalo K, Anttonen O, et al. Ventricular tachyarrhythmia as a primary presentation of sarcoidosis. Europace<\/i> 2008; 10: 760\u2013766. PMID: 18456644","DOI":"10.1093\/europace\/eun110"},{"key":"140","unstructured":"140. \u3000Kusano K. Non-pharmacological therapy for cardiac sarcoidosis - Treatment of arrhythmias in cardiac sarcoidosis. Journal of Clinical and Experimental Medicine<\/i> 2013; 247: 177\u2013181. [In Japanese]"},{"key":"141","doi-asserted-by":"crossref","unstructured":"141. \u3000Winters SL, Cohen M, Greenberg S, et al. Sustained ventricular tachycardia associated with sarcoidosis: Assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol<\/i> 1991; 18: 937\u2013943. PMID: 1894867","DOI":"10.1016\/0735-1097(91)90750-4"},{"key":"142","unstructured":"142. \u3000Perry A, Vuitch F. Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med<\/i> 1995; 119: 167\u2013172. PMID: 7848065"},{"key":"143","doi-asserted-by":"crossref","unstructured":"143. \u3000Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation<\/i> 2009; 120: 1969\u20131977. PMID: 19884472","DOI":"10.1161\/CIRCULATIONAHA.109.851352"},{"key":"144","doi-asserted-by":"crossref","unstructured":"144. \u3000Sharma S. Cardiac imaging in myocardial sarcoidosis and other cardiomyopathies. Curr Opin Pulm Med<\/i> 2009; 15: 507\u2013512. PMID: 19542892","DOI":"10.1097\/MCP.0b013e32832ea4c7"},{"key":"145","doi-asserted-by":"crossref","unstructured":"145. \u3000Yamano T, Nakatani S. Cardiac Sarcoidosis: What can we know from Echocardiography? J Echocardiogr<\/i> 2007; 5: 1\u201310.","DOI":"10.2303\/jecho.5.1"},{"key":"146","unstructured":"146. \u3000Kato Y, Morimoto S. Diagnosis and treatment of cardiac sarcoidosis. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders<\/i> 2008; 28: 15\u201324. [In Japanese]"},{"key":"147","doi-asserted-by":"crossref","unstructured":"147. \u3000Yazaki Y, Isobe M, Hayasaka M, et al. Cardiac sarcoidosis mimicking hypertrophic cardiomyopathy: Clinical utility of radionuclide imaging for differential diagnosis. Jpn Circ J<\/i> 1998; 62: 465\u2013468. PMID: 9652326","DOI":"10.1253\/jcj.62.465"},{"key":"148","doi-asserted-by":"crossref","unstructured":"148. \u3000Matsumori A, Hara M, Nagai S, et al. Hypertrophic cardiomyopathy as a manifestation of cardiac sarcoidosis. Jpn Circ J<\/i> 2000; 64: 679\u2013683. PMID: 10981852","DOI":"10.1253\/jcj.64.679"},{"key":"149","doi-asserted-by":"crossref","unstructured":"149. \u3000Okamura H, Goto Y, Terashima M, et al. Images in cardiovascular medicine. Reversible right ventricular hypertrophy due to cardiac sarcoidosis. Circulation<\/i> 2005; 111: e383\u2013e384. PMID: 15956140","DOI":"10.1161\/CIRCULATIONAHA.104.489294"},{"key":"150","doi-asserted-by":"crossref","unstructured":"150. \u3000Lam CS, Tolep KA, Metke MP, et al. Coronary sarcoidosis presenting as acute coronary syndrome. Clin Cardiol<\/i> 2009; 32: E68\u2013E71. PMID: 19330817","DOI":"10.1002\/clc.20381"},{"key":"151","doi-asserted-by":"crossref","unstructured":"151. \u3000Shiraishi J, Tatsumi T, Shimoo K, et al. Cardiac sarcoidosis mimicking right ventricular dysplasia. Circ J<\/i> 2003; 67: 169\u2013171. PMID: 12548003","DOI":"10.1253\/circj.67.169"},{"key":"152","doi-asserted-by":"crossref","unstructured":"152. \u3000Rubinstein I, Baum GL, Hiss Y. Cardiac tamponade as the presenting symptom of sarcoidosis. Am Heart J<\/i> 1985; 109: 1387\u20131388. PMID: 4003247","DOI":"10.1016\/0002-8703(85)90370-9"},{"key":"153","doi-asserted-by":"crossref","unstructured":"153. \u3000Burstow DJ, Tajik AJ, Bailey KR, et al. Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol<\/i> 1989; 63: 478\u2013482. PMID: 2916434","DOI":"10.1016\/0002-9149(89)90323-8"},{"key":"154","doi-asserted-by":"crossref","unstructured":"154. \u3000Joyce E, Ninaber MK, Katsanos S, et al. Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis. Eur J Heart Fail<\/i> 2015; 17: 51\u201362. PMID: 25431267","DOI":"10.1002\/ejhf.205"},{"key":"155","unstructured":"155. \u3000The Japanese Circulation Society. A Web report on the Japanese registry of all cardiac and vascular diseases (JROAD) in 2013 (conducted and published in 2014). http:\/\/www.j-circ.or.jp\/jittai_chosa\/jittai_chosa2013web.pdf [In Japanese]"},{"key":"156","doi-asserted-by":"crossref","unstructured":"156. \u3000Nureki S, Miyazaki E, Nishio S, et al. Interventricular septal thickening as an early manifestation of cardiac sarcoidosis. Int Heart J<\/i> 2014; 55: 181\u2013183. PMID: 24632961","DOI":"10.1536\/ihj.13-243"},{"key":"157","doi-asserted-by":"crossref","unstructured":"157. \u3000Kramer CM, Barkhausen J, Flamm SD, et al. Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized Protocols. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: Board of trustees task force on standardized protocols. J Cardiovasc Magn Reson<\/i> 2008; 10: 35. PMID: 18605997","DOI":"10.1186\/1532-429X-10-35"},{"key":"158","unstructured":"158. \u3000Herzog B, Greenwood J, Plein S. Cardiovascular Magnetic Resonance Pocket Guide 2013. ESC working group, 2013."},{"key":"159","doi-asserted-by":"crossref","unstructured":"159. \u3000Smedema JP, Snoep G, van Kroonenburgh MP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol<\/i> 2005; 45: 1683\u20131690. PMID: 15893188","DOI":"10.1016\/j.jacc.2005.01.047"},{"key":"160","doi-asserted-by":"crossref","unstructured":"160. \u3000Tadamura E, Yamamuro M, Kubo S, et al. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: Comparison with radionuclide imaging. AJR Am J Roentgenol<\/i> 2005; 185: 110\u2013115. PMID: 15972409","DOI":"10.2214\/ajr.185.1.01850110"},{"key":"161","doi-asserted-by":"crossref","unstructured":"161. \u3000Watanabe E, Kimura F, Nakajima T, et al. Late gadolinium enhancement in cardiac sarcoidosis: Characteristic magnetic resonance findings and relationship with left ventricular function. J Thorac Imaging<\/i> 2013; 28: 60\u201366. PMID: 23249970","DOI":"10.1097\/RTI.0b013e3182761830"},{"key":"162","doi-asserted-by":"crossref","unstructured":"162. \u3000Yang Y, Safka K, Graham JJ, et al. Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis. J Magn Reson Imaging<\/i> 2014; 39: 609\u2013616. PMID: 23720077","DOI":"10.1002\/jmri.24196"},{"key":"163","doi-asserted-by":"crossref","unstructured":"163. \u3000Ichinose A, Otani H, Oikawa M, et al. MRI of cardiac sarcoidosis: Basal and subepicardial localization of myocardial lesions and their effect on left ventricular function. AJR Am J Roentgenol<\/i> 2008; 191: 862\u2013869. PMID: 18716120","DOI":"10.2214\/AJR.07.3089"},{"key":"164","doi-asserted-by":"crossref","unstructured":"164. \u3000Donsky AS, Escobar J, Capehart J, et al. Heart transplantation for undiagnosed cardiac sarcoidosis. Am J Cardiol<\/i> 2002; 89: 1447\u20131450. PMID: 12062749","DOI":"10.1016\/S0002-9149(02)02368-8"},{"key":"165","doi-asserted-by":"crossref","unstructured":"165. \u3000Greulich S, Deluigi CC, Gloekler S, et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging<\/i> 2013; 6: 501\u2013511. PMID: 23498675","DOI":"10.1016\/j.jcmg.2012.10.021"},{"key":"166","doi-asserted-by":"crossref","unstructured":"166. \u3000Nagai T, Kohsaka S, Okuda S, et al. Incidence and prognostic significance of myocardial late gadolinium enhancement in patients with sarcoidosis without cardiac manifestation. Chest<\/i> 2014; 146: 1064\u20131072. PMID: 24853830","DOI":"10.1378\/chest.14-0139"},{"key":"167","doi-asserted-by":"crossref","unstructured":"167. \u3000Ise T, Hasegawa T, Morita Y, et al. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis. Heart<\/i> 2014; 100: 1165\u20131172. PMID: 24829369","DOI":"10.1136\/heartjnl-2013-305187"},{"key":"168","doi-asserted-by":"crossref","unstructured":"168. \u3000Shafee MA, Fukuda K, Wakayama Y, et al. Delayed enhancement on cardiac magnetic resonance imaging is a poor prognostic factor in patients with cardiac sarcoidosis. J Cardiol<\/i> 2012; 60: 448\u2013453. PMID: 22944174","DOI":"10.1016\/j.jjcc.2012.08.002"},{"key":"169","unstructured":"169. \u3000The Japanese Society of Nuclear Cardiology. Recommendation for 18<\/sup>F FDG PET imaging for cardiac sarcoidosis. Journal of the Japanese Society of Nuclear Cardiology<\/i> 2013; 15: 35\u201347. [In Japanese]"},{"key":"170","doi-asserted-by":"crossref","unstructured":"170. \u3000Ishida Y, Yoshinaga K, Miyagawa M, et al. Recommendations for (18) F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations. Ann Nucl Med<\/i> 2014; 28: 393\u2013403. PMID: 24464391","DOI":"10.1007\/s12149-014-0806-0"},{"key":"171","doi-asserted-by":"crossref","unstructured":"171. \u3000Isobe M, Tezuka D. Isolated cardiac sarcoidosis: Clinical characteristics, diagnosis and treatment. Int J Cardiol<\/i> 2015; 182: 132\u2013140. PMID: 25577749","DOI":"10.1016\/j.ijcard.2014.12.056"},{"key":"172","doi-asserted-by":"crossref","unstructured":"172. \u3000Schneider S, Batrice A, Rischpler C, et al. Utility of multimodal cardiac imaging with PET\/MRI in cardiac sarcoidosis: Implications for diagnosis, monitoring and treatment. Eur Heart J<\/i> 2014; 35: 312. PMID: 23975480","DOI":"10.1093\/eurheartj\/eht335"},{"key":"173","doi-asserted-by":"crossref","unstructured":"173. \u3000White JA, Rajchl M, Butler J, et al. Active cardiac sarcoidosis: First clinical experience of simultaneous positron emission tomography--magnetic resonance imaging for the diagnosis of cardiac disease. Circulation<\/i> 2013; 127: e639\u2013e641. PMID: 23733970","DOI":"10.1161\/CIRCULATIONAHA.112.001217"},{"key":"174","doi-asserted-by":"crossref","unstructured":"174. \u3000Yazaki Y. The diagnostic dilemma of isolated cardiac sarcoidosis. Intern Med<\/i> 2013; 52: 1\u20132. PMID: 23291666","DOI":"10.2169\/internalmedicine.52.9008"},{"key":"175","doi-asserted-by":"crossref","unstructured":"175. \u3000Miyazaki S, Funabashi N, Nagai T, et al. Cardiac sarcoidosis complicated with atrioventricular block and wall thinning, edema and fibrosis in left ventricle: Confirmed recovery to normal sinus rhythm and visualization of edema improvement by administration of predonisolone. Int J Cardiol<\/i> 2011; 150: e4\u2013e10. PMID: 19540005","DOI":"10.1016\/j.ijcard.2009.05.047"},{"key":"176","doi-asserted-by":"crossref","unstructured":"176. \u3000Shimada T, Shimada K, Sakane T, et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med<\/i> 2001; 110: 520\u2013527. PMID: 11343665","DOI":"10.1016\/S0002-9343(01)00677-5"},{"key":"177","doi-asserted-by":"crossref","unstructured":"177. \u3000Moon JC, Messroghli DR, Kellman P, et al; Society for Cardiovascular Magnetic Resonance Imaging; Cardiovascular Magnetic Resonance Working Group of the European Society of Cardiology. Myocardial T1 mapping and extracellular volume quantification: A Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson<\/i> 2013; 15: 92. PMID: 24124732","DOI":"10.1186\/1532-429X-15-92"},{"key":"178","doi-asserted-by":"crossref","unstructured":"178. \u3000Nakano S, Kimura F, Osman N, et al. Improved myocardial strain measured by strain-encoded magnetic resonance imaging in a patient with cardiac sarcoidosis. Can J Cardiol<\/i> 2013; 29: 1531.e9\u2013e11. PMID: 23642331","DOI":"10.1016\/j.cjca.2013.02.023"},{"key":"179","doi-asserted-by":"crossref","unstructured":"179. \u3000Hamlin SA, Henry TS, Little BP, et al. Mapping the future of cardiac MR imaging: Case-based review of T1 and T2 mapping techniques. Radiographics<\/i> 2014; 34: 1594\u20131611. PMID: 25310419","DOI":"10.1148\/rg.346140030"},{"key":"180","unstructured":"180. \u3000Pellegrino D, Bonab AA, Dragotakes SC, et al. Inflammation and infection: Imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG. J Nucl Med<\/i> 2005; 46: 1522\u20131530. PMID: 16157536"},{"key":"181","doi-asserted-by":"crossref","unstructured":"181. \u3000Koiwa H, Tsujino I, Ohira H, et al. Images in cardiovascular medicine: Imaging of cardiac sarcoid lesions using fasting cardiac 18F-fluorodeoxyglucose positron emission tomography: An autopsy case. Circulation<\/i> 2010; 122: 535\u2013536. PMID: 20679583","DOI":"10.1161\/CIRCULATIONAHA.110.952184"},{"key":"182","doi-asserted-by":"crossref","unstructured":"182. \u3000Nuutila P, Koivisto VA, Knuuti J, et al. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest<\/i> 1992; 89: 1767\u20131774. PMID: 1601987","DOI":"10.1172\/JCI115780"},{"key":"183","doi-asserted-by":"crossref","unstructured":"183. \u3000Ohira H, Tsujino I, Yoshinaga K. 18F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. Eur J Nucl Med Mol Imaging<\/i> 2011; 38: 1773\u20131783. PMID: 21559980","DOI":"10.1007\/s00259-011-1832-y"},{"key":"184","unstructured":"184. \u3000Nishiyama Y, Yamamoto Y, Fukunaga K, et al. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med<\/i> 2006; 47: 1571\u20131576. PMID: 17015889"},{"key":"185","doi-asserted-by":"crossref","unstructured":"185. \u3000Morooka M, Moroi M, Uno K, et al. Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis. EJNMMI Res<\/i> 2014; 4: 1. PMID: 24382020","DOI":"10.1186\/2191-219X-4-1"},{"key":"186","doi-asserted-by":"crossref","unstructured":"186. \u3000Ishida Y, Kiso K, Ueda H. Diagnosis of cardiac sarcoidosis by F-18 FDG PET - Usefulness and limitation. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders<\/i> 2010; 30: 77\u201380. [In Japanese]","DOI":"10.7878\/jjsogd.30.77"},{"key":"187","doi-asserted-by":"crossref","unstructured":"187. \u3000Chen S, Bokhari S. Diagnosis of cardiac sarcoidosis through mismatched defects seen on N-13 NH3\/F-18 FDG cardiac PET. Clin Nucl Med<\/i> 2011; 36: 1156\u20131157. PMID: 22064101","DOI":"10.1097\/RLU.0b013e3182336113"},{"key":"188","doi-asserted-by":"crossref","unstructured":"188. \u3000Brancato SC, Arrighi JA. Fasting FDG PET compared to MPI SPECT in cardiac sarcoidosis. J Nucl Cardiol<\/i> 2011; 18: 371\u2013374. PMID: 21318450","DOI":"10.1007\/s12350-011-9347-2"},{"key":"189","unstructured":"189. \u3000Yamagishi H, Shirai N, Takagi M, et al. Identification of cardiac sarcoidosis with 13N-NH3\/18F-FDG PET. J Nucl Med<\/i> 2003; 44: 1030\u20131036. PMID: 12843216"},{"key":"190","doi-asserted-by":"crossref","unstructured":"190. \u3000Kosuge H, Noda M, Kakuta T, et al. Left ventricular apical aneurysm in cardiac sarcoidosis. Jpn Heart J<\/i> 2001; 42: 265\u2013269. PMID: 11384087","DOI":"10.1536\/jhj.42.265"},{"key":"191","doi-asserted-by":"crossref","unstructured":"191. \u3000Egashira T, Makino S, Kunitomi A, et al. Necessity for rule out coronary artery disease with the positive findings of 18<\/sup>F-FDG-PET in case of systemic sarcoidosis. Int J Cardiol<\/i> 2014; 172: e401\u2013e402. PMID: 24461987","DOI":"10.1016\/j.ijcard.2013.12.259"},{"key":"192","doi-asserted-by":"crossref","unstructured":"192. \u3000Tung R, Bauer B, Schelbert H, et al. Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis. Heart Rhythm<\/i> 2015; 12: 2488\u20132498. PMID: 26272522","DOI":"10.1016\/j.hrthm.2015.08.014"},{"key":"193","unstructured":"193. \u3000Berry JJ, Baker JA, Pieper KS, et al. The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers. J Nucl Med<\/i> 1991; 32: 1518\u20131525. PMID: 1869972"},{"key":"194","unstructured":"194. \u3000Bartlett ML, Bacharach SL, Voipio-Pulkki LM, et al. Artifactual in homogeneities in myocardial PET and SPECT scans in normal subjects. J Nucl Med<\/i> 1995; 36: 188\u2013195. PMID: 7830111"},{"key":"195","unstructured":"195. \u3000Gropler RJ, Siegel BA, Lee KJ, et al. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med<\/i> 1990; 31: 1749\u20131756. PMID: 2230987"},{"key":"196","unstructured":"196. \u3000Ishida Y, Yasumura Y, Fukuchi K, et al. Increased myocardial glucose utilization in the fasting state as a metabolic indicator of severity of heart failure: A study by F-18 FDG PET. In: Nagara T, Tsukamoto E, Kuge Y, et al. editors. Positron emission tomography in the millennium. Elsevier Science 2000; 121\u2013126."},{"key":"197","doi-asserted-by":"crossref","unstructured":"197. \u3000D\u00e1vila-Rom\u00e1n VG, Vedala G, Herrero P, et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol<\/i> 2002; 40: 271\u2013277. PMID: 12106931","DOI":"10.1016\/S0735-1097(02)01967-8"},{"key":"198","doi-asserted-by":"crossref","unstructured":"198. \u3000Langah R, Spicer K, Gebregziabher M, et al. Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis. J Nucl Cardiol<\/i> 2009; 16: 801\u2013810. PMID: 19548047","DOI":"10.1007\/s12350-009-9110-0"},{"key":"199","doi-asserted-by":"crossref","unstructured":"199. \u3000Ohira H, Tsujino I, Ishimaru S, et al. Myocardial imaging with 18<\/sup>F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging<\/i> 2008; 35: 933\u2013941. PMID: 18084757","DOI":"10.1007\/s00259-007-0650-8"},{"key":"200","unstructured":"200. \u3000Okumura W, Iwasaki T, Toyama T, et al. Usefulness of fasting 18<\/sup>F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med<\/i> 2004; 45: 1989\u20131998. PMID: 15585472"},{"key":"201","doi-asserted-by":"crossref","unstructured":"201. \u3000Ishimaru S, Tsujino I, Takei T, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J<\/i> 2005; 26: 1538\u20131543. PMID: 15809286","DOI":"10.1093\/eurheartj\/ehi180"},{"key":"202","doi-asserted-by":"crossref","unstructured":"202. \u3000Youssef G, Leung E, Mylonas I, et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: A systematic review and metaanalysis including the Ontario experience. J Nucl Med<\/i> 2012; 53: 241\u2013248. PMID: 22228794","DOI":"10.2967\/jnumed.111.090662"},{"key":"203","doi-asserted-by":"crossref","unstructured":"203. \u3000Mc Ardle BA, Birnie DH, Klein R, et al. Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by 18<\/sup>F-fluorodeoxyglucose positron emission tomography? Circ Cardiovasc Imaging<\/i> 2013; 6: 617\u2013626. PMID: 23884290","DOI":"10.1161\/CIRCIMAGING.112.000289"},{"key":"204","doi-asserted-by":"crossref","unstructured":"204. \u3000Blankstein R, Osborne M, Naya M, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol<\/i> 2014; 63: 329\u2013336. PMID: 24140661","DOI":"10.1016\/j.jacc.2013.09.022"},{"key":"205","unstructured":"205. \u3000Ishida Y. Treatment of cardiac sarcoidosis and nuclear imaging. In: Clinical applications of cardiac nuclear imaging - Clinical cases and explanations. Medical Review, 2010; 111\u2013113. [In Japanese]"},{"key":"206","doi-asserted-by":"crossref","unstructured":"206. \u3000Osborne MT, Hulten EA, Singh A, et al. Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol<\/i> 2014; 21: 166\u2013174. PMID: 24307261","DOI":"10.1007\/s12350-013-9828-6"},{"key":"207","doi-asserted-by":"crossref","unstructured":"207. \u3000Lynch JP 3rd, Hwang J, Bradfield J, et al. Cardiac involvement in sarcoidosis: Evolving concepts in diagnosis and treatment. Semin Respir Crit Care Med<\/i> 2014; 35: 372\u2013390. PMID: 25007089","DOI":"10.1055\/s-0034-1376889"},{"key":"208","doi-asserted-by":"crossref","unstructured":"208. \u3000Schatka I, Bengel FM. Advanced imaging of cardiac sarcoidosis. J Nucl Med<\/i> 2014; 55: 99\u2013106. PMID: 24232870","DOI":"10.2967\/jnumed.112.115121"},{"key":"209","doi-asserted-by":"crossref","unstructured":"209. \u3000Okayama K, Kurata C, Tawarahara K, et al. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest<\/i> 1995; 107: 330\u2013334. PMID: 7842756","DOI":"10.1378\/chest.107.2.330"},{"key":"210","doi-asserted-by":"crossref","unstructured":"210. \u3000Taki J, Nakajima K, Bunko H, et al. Cardiac sarcoidosis demonstrated by Tl-201 and Ga-67 SPECT imaging. Clin Nucl Med<\/i> 1990; 15: 636\u2013639. PMID: 2208885","DOI":"10.1097\/00003072-199009000-00010"},{"key":"211","doi-asserted-by":"crossref","unstructured":"211. \u3000Tawarahara K, Kurata C, Okayama K, et al. Thallium-201 and gallium 67 single photon emission computed tomographic imaging in cardiac sarcoidosis. Am Heart J<\/i> 1992; 124: 1383\u20131384. PMID: 1442515","DOI":"10.1016\/0002-8703(92)90431-T"},{"key":"212","doi-asserted-by":"crossref","unstructured":"212. \u3000Momose M, Kadoya M, Koshikawa M, et al. Usefulness of 67<\/sup>Ga SPECT and integrated low-dose CT scanning (SPECT\/CT) in the diagnosis of cardiac sarcoidosis. Ann Nucl Med<\/i> 2007; 21: 545\u2013551. PMID: 18092130","DOI":"10.1007\/s12149-007-0064-5"},{"key":"213","unstructured":"213. \u3000Kiso K, Hashimura K, Ishida Y, et al. Clinical Utility of Hybrid SPECT\/CT System for the Diagnosis of Cardiac Sarcoidosis. Circ J<\/i> 2010; 74(Suppl I): 293\u2013294."},{"key":"214","doi-asserted-by":"crossref","unstructured":"214. \u3000Bulkley BH, Rouleau JR, Whitaker JQ, et al. The use of 201thallium for myocardial perfusion imaging in sarcoid heart disease. Chest<\/i> 1977; 72: 27\u201332. PMID: 872650","DOI":"10.1378\/chest.72.1.27"},{"key":"215","doi-asserted-by":"crossref","unstructured":"215. \u3000Kinney EL, Jackson GL, Reeves WC, et al. Thallium-scan myocardial defects and echocardiographic abnormalities in patients with sarcoidosis without clinical cardiac dysfunction: An analysis of 44 patients. Am J Med<\/i> 1980; 68: 497\u2013503. PMID: 7369231","DOI":"10.1016\/0002-9343(80)90292-2"},{"key":"216","doi-asserted-by":"crossref","unstructured":"216. \u3000Hirose Y, Ishida Y, Hayashida K, et al. Myocardial involvement in patients with sarcoidosis: An analysis of 75 patients. Clin Nucl Med<\/i> 1994; 19: 522\u2013526. PMID: 8062473","DOI":"10.1097\/00003072-199406000-00012"},{"key":"217","doi-asserted-by":"crossref","unstructured":"217. \u3000Forman MB, Sandler MP, Sacks GA, et al. Radionuclide imaging in myocardial sarcoidosis: Demonstration of myocardial uptake of technetium pyrophosphate99 m and gallium. Chest<\/i> 1983; 83: 578\u2013580. PMID: 6297857","DOI":"10.1378\/chest.83.3.578"},{"key":"218","doi-asserted-by":"crossref","unstructured":"218. \u3000Le Guludec D, Menad F, Faraggi M, et al. Myocardial sarcoidosis. Clinical value of technetium-99 m sestamibi tomoscintigraphy. Chest<\/i> 1994; 106: 1675\u20131682. PMID: 7988183","DOI":"10.1378\/chest.106.6.1675"},{"key":"219","doi-asserted-by":"crossref","unstructured":"219. \u3000Eguchi M, Tsuchihashi K, Hotta D, et al. Technetium-99 m sestamibi\/tetrofosmin myocardial perfusion scanning in cardiac and noncardiac sarcoidosis. Cardiology<\/i> 2000; 94: 193\u2013199. PMID: 11279326","DOI":"10.1159\/000047316"},{"key":"220","doi-asserted-by":"crossref","unstructured":"220. \u3000Tellier P, Paycha F, Antony I, et al. Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis. Am J Med<\/i> 1988; 85: 189\u2013193. PMID: 3400694","DOI":"10.1016\/S0002-9343(88)80340-1"},{"key":"221","doi-asserted-by":"crossref","unstructured":"221. \u3000Tellier P, Valeyre D, Nitenberg A, et al. Cardiac sarcoidosis: Reversion of myocardial perfusion abnormalities by dipyridamole. Eur J Nucl Med<\/i> 1985; 11: 201\u2013204. PMID: 4076228","DOI":"10.1007\/BF00279069"},{"key":"222","doi-asserted-by":"crossref","unstructured":"222. \u3000Butany J, Bahl NE, Morales K, et al. The intricacies of cardiac sarcoidosis: A case report involving the coronary arteries and a review of the literature. Cardiovasc Pathol<\/i> 2006; 15: 222\u2013227. PMID: 16844554","DOI":"10.1016\/j.carpath.2006.02.005"},{"key":"223","doi-asserted-by":"crossref","unstructured":"223. \u3000Barton JH, Tavora F, Farb A, et al. Unusual cardiovascular manifestations of sarcoidosis, a report of three cases: Coronary artery aneurysm with myocardial infarction, symptomatic mitral valvular disease, and sudden death from ruptured splenic artery. Cardiovasc Pathol<\/i> 2010; 19: e119\u2013e123. PMID: 19502084","DOI":"10.1016\/j.carpath.2009.04.006"},{"key":"224","unstructured":"224. \u3000The Japanese Circulation Society. Guidelines for management of dilated cardiomyopathy and secondary cardiomyopathy (JCS 2011). http:\/\/www.j-circ.or.jp\/guideline\/pdf\/JCS2011_tomoike_h.pdf [In Japanese]"},{"key":"225","doi-asserted-by":"crossref","unstructured":"225. \u3000Fox KF, Cowie MR, Wood DA, et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J<\/i> 2001; 22: 228\u2013236. PMID: 11161934","DOI":"10.1053\/euhj.2000.2289"},{"key":"226","doi-asserted-by":"crossref","unstructured":"226. \u3000Arques S, Ambrosi P, Gelisse R, et al. Prevalence of angiographic coronary artery disease in patients hospitalized for acute diastolic heart failure without clinical and electrocardiographic evidence of myocardial ischemia on admission. Am J Cardiol<\/i> 2004; 94: 133\u2013135. PMID: 15219526","DOI":"10.1016\/j.amjcard.2004.03.046"},{"key":"227","doi-asserted-by":"crossref","unstructured":"227. \u3000Kurtz CE, Gerber Y, Weston SA, et al. Use of ejection fraction tests and coronary angiography in patients with heart failure. Mayo Clin Proc<\/i> 2006; 81: 906\u2013913. PMID: 16835970","DOI":"10.4065\/81.7.906"},{"key":"228","doi-asserted-by":"crossref","unstructured":"228. \u3000Bluemke DA, Achenbach S, Budoff M, et al. Noninvasive coronary artery imaging: Magnetic resonance angiography and multidetector computed tomography angiography: A scientific statement from the american heart association committee on cardiovascular imaging and intervention of the council on cardiovascular radiology and intervention, and the councils on clinical cardiology and cardiovascular disease in the young. Circulation<\/i> 2008; 118: 586\u2013606. PMID: 18586979","DOI":"10.1161\/CIRCULATIONAHA.108.189695"},{"key":"229","unstructured":"229. \u3000Lynch JP 3rd, Sharma OP, Baughman RP. Extrapulmonary sarcoidosis. Semin Respir Infect<\/i> 1998; 13: 229\u2013254. PMID: 9764954"},{"key":"230","doi-asserted-by":"crossref","unstructured":"230. \u3000Sato T, Kanzaki H, Ishida Y, et al. Second left ventricular aneurysm newly developed in a patient with untreated cardiac sarcoidosis. Circ J<\/i> 2010; 74: 2477\u20132478. PMID: 20890051","DOI":"10.1253\/circj.CJ-10-0139"},{"key":"231","unstructured":"231. \u3000Candell Riera J, Bardaj\u00ed Ruiz A, Sangrist\u00e1 Sauleda J, et al. [Left ventricular aneurysm in sarcoidosis: Its detection by isotopic ventriculography]. Rev Esp Cardiol<\/i> 1986; 39: 151\u2013153. PMID: 3726242"},{"key":"232","doi-asserted-by":"crossref","unstructured":"232. \u3000Miyahara S, Mukohara N, Morimoto N, et al. Left ventricular restoration for cardiac sarcoidosis: Report of two cases. Surg Today<\/i> 2014; 44: 568\u2013571. PMID: 23271666","DOI":"10.1007\/s00595-012-0409-0"},{"key":"233","doi-asserted-by":"crossref","unstructured":"233. \u3000Altay H, Altin C, Coner A, et al. Normal coronary artery patient presenting with left ventricular aneurysm. Case Rep Med<\/i> 2011; 2011: 183050. PMID: 21845194","DOI":"10.1155\/2011\/183050"},{"key":"234","doi-asserted-by":"crossref","unstructured":"234. \u3000Marks A, Anderson MH, Harrison NK. Ventricular aneurysm secondary to sarcoid disease. Heart<\/i> 2004; 90: 694. PMID: 15145887","DOI":"10.1136\/hrt.2003.023630"},{"key":"235","doi-asserted-by":"crossref","unstructured":"235. \u3000Toda G, Iliev II, Kawahara F, et al. Left ventricular aneurysm without coronary artery disease, incidence and clinical features: Clinical analysis of 11 cases. Intern Med<\/i> 2000; 39: 531\u2013536. PMID: 10888207","DOI":"10.2169\/internalmedicine.39.531"},{"key":"236","doi-asserted-by":"crossref","unstructured":"236. \u3000Miyazawa K, Yoshikawa T, Takamisawa I, et al. Presence of ventricular aneurysm predicts poor clinical outcomes in patients with cardiac sarcoidosis. Int J Cardiol<\/i> 2014; 177: 720\u2013722. PMID: 25456577","DOI":"10.1016\/j.ijcard.2014.10.024"},{"key":"237","doi-asserted-by":"crossref","unstructured":"237. \u3000Sakakibara S, Konno S. Endomyocardial biopsy. Jpn Heart J<\/i> 1962; 3: 537\u2013543. PMID: 13990927","DOI":"10.1536\/ihj.3.537"},{"key":"238","doi-asserted-by":"crossref","unstructured":"238. \u3000Ardehali H, Howard DL, Hariri A, et al. A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. Am Heart J<\/i> 2005; 150: 459\u2013463. PMID: 16169324","DOI":"10.1016\/j.ahj.2004.10.006"},{"key":"239","doi-asserted-by":"crossref","unstructured":"239. \u3000Morimoto S, Kato S, Hiramitsu S, et al. Narrowing of the left ventricular cavity associated with transient ventricular wall thickening reduces stroke volume in patients with acute myocarditis. Circ J<\/i> 2003; 67: 490\u2013494. PMID: 12808264","DOI":"10.1253\/circj.67.490"},{"key":"240","unstructured":"240. \u3000Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol<\/i> 2007; 50: 1914\u20131931. PMID: 17980265"},{"key":"241","unstructured":"241. \u3000Falk HR, Hershberger ER. The dilated, restrictive, and infiltrative cardiomyopathies. In: Mann LD, Zipes PD, Libby P, et al, editors. Braunwald\u2019s Heart Disease 10th edn. Elservier Saunders 2015. 1551\u20131573."},{"key":"242","doi-asserted-by":"crossref","unstructured":"242. \u3000Hiramitsu S, Hiroe M, Morimoto S, et al. National survey of the use of endomyocardial biopsy in Japan. Jpn Circ J<\/i> 1998; 62: 909\u2013912. PMID: 9890204","DOI":"10.1253\/jcj.62.909"},{"key":"243","doi-asserted-by":"crossref","unstructured":"243. \u3000Tsang TS, Freeman WK, Barnes ME, et al. Rescue echocardiographically guided pericardiocentesis for cardiac perforation complicating catheter-based procedures. The Mayo Clinic experience. J Am Coll Cardiol<\/i> 1998; 32: 1345\u20131350. PMID: 809946","DOI":"10.1016\/S0735-1097(98)00390-8"},{"key":"244","doi-asserted-by":"crossref","unstructured":"244. \u3000Casella M, Pizzamiglio F, Dello Russo A, et al. Feasibility of combined unipolar and bipolar voltage maps to improve sensitivity of endomyocardial biopsy. Circ Arrhythm Electrophysiol<\/i> 2015; 8: 625\u2013632. PMID: 25829163","DOI":"10.1161\/CIRCEP.114.002216"},{"key":"245","unstructured":"245. \u3000Morimoto S, Uemura A, Hiramitsu S. Revised guidelines for the diagnosis of cardiac sarcoidosis. Respiration and Circulation<\/i> 2006; 54: 955\u2013961. [In Japanese]"},{"key":"246","doi-asserted-by":"crossref","unstructured":"246. \u3000Tanaka T. Pathology of sarcoidosis and granulomatous lung disease. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders<\/i> 2013; 33: 23\u201326. [In Japanese]","DOI":"10.7878\/jjsogd.33.23"},{"key":"247","doi-asserted-by":"crossref","unstructured":"247. \u3000Kul S, Ozcelik HK, Uyarel H, et al. Diagnostic value of strain echocardiography, galectin-3, and tenascin-C levels for the identification of patients with pulmonary and cardiac sarcoidosis. Lung<\/i> 2014; 192: 533\u2013542. PMID: 24777587","DOI":"10.1007\/s00408-014-9586-5"},{"key":"248","doi-asserted-by":"crossref","unstructured":"248. \u3000Banba K, Kusano KF, Nakamura K, et al. Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. Heart Rhythm<\/i> 2007; 4: 1292\u20131299. PMID: 17905334","DOI":"10.1016\/j.hrthm.2007.06.006"},{"key":"249","doi-asserted-by":"crossref","unstructured":"249. \u3000Kumar S, Barbhaiya C, Nagashima K, et al. Ventricular tachycardia in cardiac sarcoidosis: Characterization of ventricular substrate and outcomes of catheter ablation. Circ Arrhythm Electrophysiol<\/i> 2015; 8: 87\u201393. PMID: 25527825","DOI":"10.1161\/CIRCEP.114.002145"},{"key":"250","doi-asserted-by":"crossref","unstructured":"250. \u3000Naruse Y, Sekiguchi Y, Nogami A, et al. Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis. Circ Arrhythm Electrophysiol<\/i> 2014; 7: 407\u2013413. PMID: 24837644","DOI":"10.1161\/CIRCEP.113.000734"},{"key":"251","doi-asserted-by":"crossref","unstructured":"251. \u3000Mezaki T, Chinushi M, Washizuka T, et al. Discrepancy between inducibility of ventricular tachycardia and activity of cardiac sarcoidosis: Requirement of defibrillator implantation for the inactive stage of cardiac sarcoidosis. Intern Med<\/i> 2001; 40: 731\u2013735. PMID: 11518112","DOI":"10.2169\/internalmedicine.40.731"},{"key":"252","doi-asserted-by":"crossref","unstructured":"252. \u3000Nadel J, Lancefield T, Voskoboinik A, et al. Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death. Eur Heart J Cardiovasc Imaging<\/i> 2015; 16: 634\u2013641. PMID: 25617029","DOI":"10.1093\/ehjci\/jeu294"},{"key":"253","doi-asserted-by":"crossref","unstructured":"253. \u3000Huang PL, Brooks R, Carpenter C, et al. Antiarrhythmic therapy guided by programmed electrical stimulation in cardiac sarcoidosis with ventricular tachycardia. Am Heart J<\/i> 1991; 121: 599\u2013601. PMID: 1990769","DOI":"10.1016\/0002-8703(91)90734-Y"},{"key":"254","doi-asserted-by":"crossref","unstructured":"254. \u3000Aizer A, Stern EH, Gomes JA, et al. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J Cardiol<\/i> 2005; 96: 276\u2013282. PMID: 16018857","DOI":"10.1016\/j.amjcard.2005.03.059"},{"key":"255","doi-asserted-by":"crossref","unstructured":"255. \u3000Mehta D, Mori N, Goldbarg SH, et al. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: Role of programmed ventricular stimulation. Circ Arrhythm Electrophysiol<\/i> 2011; 4: 43\u201348. PMID: 21193539","DOI":"10.1161\/CIRCEP.110.958322"},{"key":"256","doi-asserted-by":"crossref","unstructured":"256. \u3000Sato H, Woodhead FA, Ahmad T, et al. Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Hum Mol Genet<\/i> 2010; 19: 4100\u20134111. PMID: 20685690","DOI":"10.1093\/hmg\/ddq325"},{"key":"257","doi-asserted-by":"crossref","unstructured":"257. \u3000Pasturenzi L, Martinetti M, Cuccia M, et al. HLA class I, II, and III polymorphism in Italian patients with sarcoidosis: The Pavia-Padova Sarcoidosis Study Group. Chest<\/i> 1993; 104: 1170\u20131175. PMID: 8404186","DOI":"10.1378\/chest.104.4.1170"},{"key":"258","doi-asserted-by":"crossref","unstructured":"258. \u3000Gardner J, Kennedy HG, Hamblin A, et al. HLA associations in sarcoidosis: A study of two ethnic groups. Thorax<\/i> 1984; 39: 19\u201322. PMID: 6582657","DOI":"10.1136\/thx.39.1.19"},{"key":"259","doi-asserted-by":"crossref","unstructured":"259. \u3000Ishihara M. Study of susceptibility genes for sarcoidosis. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders<\/i> 2013; 33: 11\u201317. [In Japanese]","DOI":"10.7878\/jjsogd.33.11"},{"key":"260","doi-asserted-by":"crossref","unstructured":"260. \u3000Rybicki BA, Walewski JL, Maliarik MJ, et al. ACCESS Research Group. The BTNL2<\/i> gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet<\/i> 2005; 77: 491\u2013499. PMID: 16080124","DOI":"10.1086\/444435"},{"key":"261","doi-asserted-by":"crossref","unstructured":"261. \u3000Levin AM, Iannuzzi MC, Montgomery CG, et al. Association of ANXA11 genetic variation with sarcoidosis in African Americans and European Americans. Genes Immun<\/i> 2013; 14: 13\u201318. PMID: 23151485","DOI":"10.1038\/gene.2012.48"},{"key":"262","doi-asserted-by":"crossref","unstructured":"262. \u3000Wijnen PA, Cremers JP, Nelemans PJ, et al. Association of the TNF-\u03b1 G-308A polymorphism with TNF-inhibitor response in sarcoidosis. Eur Respir J<\/i> 2014; 43: 1730\u20131739. PMID: 24558177","DOI":"10.1183\/09031936.00169413"},{"key":"263","doi-asserted-by":"crossref","unstructured":"263. \u3000Langrish CL, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med<\/i> 2005; 201: 233\u2013240. PMID: 15657292","DOI":"10.1084\/jem.20041257"},{"key":"264","doi-asserted-by":"crossref","unstructured":"264. \u3000Facco M, Cabrelle A, Teramo A, et al. Sarcoidosis is a Th1\/Th17 multisystem disorder. Thorax<\/i> 2011; 66: 144\u2013150. PMID: 21139119","DOI":"10.1136\/thx.2010.140319"},{"key":"265","doi-asserted-by":"crossref","unstructured":"265. \u3000Huang H, Lu Z, Jiang C, et al. Imbalance between Th17 and regulatory T-Cells in sarcoidosis. Int J Mol Sci<\/i> 2013; 14: 21463\u201321473. PMID: 24177566","DOI":"10.3390\/ijms141121463"},{"key":"266","unstructured":"266. \u3000Judson MA, Baughman RP, Teirstein AS, et al. Defining organ involvement in sarcoidosis: The ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis<\/i> 1999; 16: 75\u201386. PMID: 10207945"},{"key":"267","unstructured":"267. \u3000Judson MA, Costabel U, Drent M, et al. The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis<\/i> 2014; 31: 19\u201327. PMID: 24751450"},{"key":"268","unstructured":"268. \u3000The Ministry of Health, Labour and Welfare. Intractable diseases designated as of January 1, 2015 (new diseases). http:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000062437.html [In Japanese]"},{"key":"269","doi-asserted-by":"crossref","unstructured":"269. \u3000Nery PB, Mc Ardle BA, Redpath CJ, et al. Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia. Pacing Clin Electrophysiol<\/i> 2014; 37: 364\u2013374. PMID: 24102263","DOI":"10.1111\/pace.12277"},{"key":"270","doi-asserted-by":"crossref","unstructured":"270. \u3000Koplan BA, Soejima K, Baughman K, et al. Refractory ventricular tachycardia secondary to cardiac sarcoid: Electrophysiologic characteristics, mapping, and ablation. Heart Rhythm<\/i> 2006; 3: 924\u2013929. PMID: 16876741","DOI":"10.1016\/j.hrthm.2006.03.031"},{"key":"271","doi-asserted-by":"crossref","unstructured":"271. \u3000Patel AR, Klein MR, Chandra S, et al. Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: An observational study. Eur J Heart Fail<\/i> 2011; 13: 1231\u20131237. PMID: 21810833","DOI":"10.1093\/eurjhf\/hfr099"},{"key":"272","doi-asserted-by":"crossref","unstructured":"272. \u3000Cummings KW, Bhalla S, Javidan-Nejad C, et al. A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging. Radiographics<\/i> 2009; 29: 89\u2013103. PMID: 19168838","DOI":"10.1148\/rg.291085052"},{"key":"273","doi-asserted-by":"crossref","unstructured":"273. \u3000Kato Y. Solitary cardiac involvement of sarcoidosis. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders<\/i> 2012; 32: 51\u201354. [In Japanese]","DOI":"10.7878\/jjsogd.32.51"},{"key":"274","doi-asserted-by":"crossref","unstructured":"274. \u3000Tezuka D, Terashima M, Kato Y, et al. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: Application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography\/computerized tomography. J Card Fail<\/i> 2015; 21: 313\u2013322. PMID: 25512195","DOI":"10.1016\/j.cardfail.2014.12.004"},{"key":"275","doi-asserted-by":"crossref","unstructured":"275. \u3000Brown ML, Reeder G, Unni KK, et al. Intraoperative diagnosis of isolated cardiac sarcoid. Heart Lung Circ<\/i> 2007; 16: 315\u2013317. PMID: 17254847","DOI":"10.1016\/j.hlc.2006.07.009"},{"key":"276","doi-asserted-by":"crossref","unstructured":"276. \u3000Sugizaki Y, Tanaka H, Imanishi J, et al. Isolated primary cardiac sarcoidosis presenting as acute heart failure. Intern Med<\/i> 2013; 52: 71\u201374. PMID: 23291676","DOI":"10.2169\/internalmedicine.52.8470"},{"key":"277","doi-asserted-by":"crossref","unstructured":"277. \u3000Nery PB, Keren A, Healey J, et al. Isolated cardiac sarcoidosis: Establishing the diagnosis with electroanatomic mapping-guided endomyocardial biopsy. Can J Cardiol<\/i> 2013; 29: 1015.e1\u2013e3. PMID: 23246240","DOI":"10.1016\/j.cjca.2012.09.009"},{"key":"278","doi-asserted-by":"crossref","unstructured":"278. \u3000Meyer T, Lauschke J, Ruppert V, et al. Isolated cardiac sarcoidosis associated with the expression of a splice variant coding for a truncated BTNL2 protein. Cardiology<\/i> 2008; 109: 117\u2013121. PMID: 17703092","DOI":"10.1159\/000105552"},{"key":"279","doi-asserted-by":"crossref","unstructured":"279. \u3000Galati G, Leone O, Rapezzi C. The difficult diagnosis of isolated cardiac sarcoidosis: Usefulness of an integrated MRI and PET approach. Heart<\/i> 2014; 100: 89\u201390. PMID: 23838000","DOI":"10.1136\/heartjnl-2013-304237"},{"key":"280","doi-asserted-by":"crossref","unstructured":"280. \u3000Tsai JH, Chou NK, Wang SS, et al. Isolated cardiac sarcoidosis: Case experience in heart transplantation. J Formos Med Assoc<\/i> 2013; 112: 499\u2013500. PMID: 24016616","DOI":"10.1016\/j.jfma.2011.12.010"},{"key":"281","doi-asserted-by":"crossref","unstructured":"281. \u3000Kandolin R, Lehtonen J, Kupari M. Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol<\/i> 2011; 4: 303\u2013309. PMID: 21427276","DOI":"10.1161\/CIRCEP.110.959254"},{"key":"282","doi-asserted-by":"crossref","unstructured":"282. \u3000Kandolin R, Lehtonen J, Airaksinen J, et al. Cardiac sarcoidosis: Epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation<\/i> 2015; 131: 624\u2013632. PMID: 25527698","DOI":"10.1161\/CIRCULATIONAHA.114.011522"},{"key":"283","unstructured":"283. \u3000Tsuchida A, Clinical characteristics of patients newly diagnosed as cardiac sarcoidosis - Five-year experience. Abstract of the 62nd annual scientific session of the Japanese College Cardiology 2014: P-075. [In Japanese]"},{"key":"284","unstructured":"284. \u3000Sugie T, Hashimoto N, Iwai K. Clinical and autopsy studies on prognosis of sarcoidosis. Nihon Rinsho<\/i> 1994; 52: 1567\u20131570. [In Japanese]"},{"key":"285","doi-asserted-by":"crossref","unstructured":"285. \u3000Kim JS, Judson MA, Donnino R, et al. Cardiac sarcoidosis. Am Heart J<\/i> 2009; 157: 9\u201321. PMID: 19081391","DOI":"10.1016\/j.ahj.2008.09.009"},{"key":"286","unstructured":"286. \u3000Yazaki Y. Diagnosis of cardiac sarcoidosis in the era of multimodality cardiac imaging. SHINZO<\/i> 1995; 47: 1046\u20131049. [In Japanese]"},{"key":"287","doi-asserted-by":"crossref","unstructured":"287. \u3000Terasaki F, Ishizaka N. Deterioration of cardiac function during the progression of cardiac sarcoidosis: Diagnosis and treatment. Intern Med<\/i> 2014; 53: 1595\u20131605. PMID: 25088870","DOI":"10.2169\/internalmedicine.53.2784"},{"key":"288","doi-asserted-by":"crossref","unstructured":"288. \u3000Terasaki F, Ishizaka N. Reversal of cardiac remodeling after treatment of IgG4 related cholangitis - Possibility of IgG4-related heart disease? Int J Cardiol<\/i> 2016; 223: 477\u2013478. PMID: 27544609","DOI":"10.1016\/j.ijcard.2016.08.256"},{"key":"289","doi-asserted-by":"crossref","unstructured":"289. \u3000Grutters JC, van den Bosch JM. Corticosteroid treatment in sarcoidosis. Eur Respir J<\/i> 2006; 28: 627\u2013636. PMID: 16946094","DOI":"10.1183\/09031936.06.00105805"},{"key":"290","doi-asserted-by":"crossref","unstructured":"290. \u3000Bussinguer M, Danielian A, Sharma OP. Cardiac sarcoidosis: Diagnosis and management. Curr Treat Options Cardiovasc Med<\/i> 2012; 14: 652\u2013664. PMID: 22983661","DOI":"10.1007\/s11936-012-0208-3"},{"key":"291","doi-asserted-by":"crossref","unstructured":"291. \u3000Chiu CZ, Nakatani S, Zhang G, et al. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol<\/i> 2005; 95: 143\u2013146. PMID: 15619415","DOI":"10.1016\/j.amjcard.2004.08.083"},{"key":"292","doi-asserted-by":"crossref","unstructured":"292. \u3000Nagai T, Nagano N, Sugano Y, et al. Effect of corticosteroid therapy on long-term clinical outcome and left ventricular function in patients with cardiac sarcoidosis. Circ J<\/i> 2015; 79: 1593\u20131600. PMID: 25877828","DOI":"10.1253\/circj.CJ-14-1275"},{"key":"293","doi-asserted-by":"crossref","unstructured":"293. \u3000Chapelon-Abric C, de Zuttere D, Duhaut P, et al. Cardiac sarcoidosis: A retrospective study of 41 cases. Medicine (Baltimore)<\/i> 2004; 83: 315\u2013334. PMID: 15525844","DOI":"10.1097\/01.md.0000145367.17934.75"},{"key":"294","unstructured":"294. \u3000Hiramitsu S, Morimoto S, Uemura A, et al. National survey on status of steroid therapy for cardiac sarcoidosis in Japan. Sarcoidosis Vasc Diffuse Lung Dis<\/i> 2005; 22: 210\u2013213. PMID: 16315784"},{"key":"295","doi-asserted-by":"crossref","unstructured":"295. \u3000Yazaki Y. How should we evaluate the activity of myocardial inflammation and guide corticosteroid treatment in patients with cardiac sarcoidosis? Circ J<\/i> 2015; 79: 1450\u20131452. PMID: 26063083","DOI":"10.1253\/circj.CJ-15-0583"},{"key":"296","doi-asserted-by":"crossref","unstructured":"296. \u3000Demeter SL. Myocardial sarcoidosis unresponsive to steroids. Treatment with cyclophosphamide. Chest<\/i> 1988; 94: 202\u2013203. PMID: 3383636","DOI":"10.1378\/chest.94.1.202"},{"key":"297","doi-asserted-by":"crossref","unstructured":"297. \u3000Wyser CP, van Schalkwyk EM, Alheit B, et al. Treatment of progressive pulmonary sarcoidosis with cyclosporin A: A randomized controlled trial. Am J Respir Crit Care Med<\/i> 1997; 156: 1371\u20131376. PMID: 9372647","DOI":"10.1164\/ajrccm.156.5.9506031"},{"key":"298","doi-asserted-by":"crossref","unstructured":"298. \u3000M\u00fcller-Quernheim J, Kienast K, Held M, et al. Treatment of chronic sarcoidosis with an azathioprine\/prednisolone regimen. Eur Respir J<\/i> 1999; 14: 1117\u20131122. PMID: 10596700","DOI":"10.1183\/09031936.99.14511179"},{"key":"299","doi-asserted-by":"crossref","unstructured":"299. \u3000Baughman RP, Lower EE. A clinical approach to the use of methotrexate for sarcoidosis. Thorax<\/i> 1999; 54: 742\u2013746. PMID: 10413729","DOI":"10.1136\/thx.54.8.742"},{"key":"300","doi-asserted-by":"crossref","unstructured":"300. \u3000Carlesimo M, Giustini S, Rossi A, et al. Treatment of cutaneous and pulmonary sarcoidosis with thalidomide. J Am Acad Dermatol<\/i> 1995; 32: 866\u2013869. PMID: 7722046","DOI":"10.1016\/0190-9622(95)91549-4"},{"key":"301","doi-asserted-by":"crossref","unstructured":"301. \u3000Baltzan M, Mehta S, Kirkham TH, et al. Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. Am J Respir Crit Care Med<\/i> 1999; 160: 192\u2013197. PMID: 10390399","DOI":"10.1164\/ajrccm.160.1.9809024"},{"key":"302","doi-asserted-by":"crossref","unstructured":"302. \u3000Zabel P, Entzian P, Dalhoff K, et al. Pentoxifylline in treatment of sarcoidosis. Am J Respir Crit Care Med<\/i> 1997; 155: 1665\u20131669. PMID: 9154873","DOI":"10.1164\/ajrccm.155.5.9154873"},{"key":"303","doi-asserted-by":"crossref","unstructured":"303. \u3000Kikuchi N, Nunoda S, Serizawa N, et al. Combination therapy with corticosteroid and mycophenolate mofetil in a case of refractory cardiac sarcoidosis. J Cardiol Cases<\/i> 2016; 13: 125\u2013128.","DOI":"10.1016\/j.jccase.2015.12.008"},{"key":"304","doi-asserted-by":"crossref","unstructured":"304. \u3000Vorselaars AD, Cremers JP, Grutters JC, et al. Cytotoxic agents in sarcoidosis: Which one should we choose? Curr Opin Pulm Med<\/i> 2014; 20: 479\u2013487. PMID: 25046427","DOI":"10.1097\/MCP.0000000000000078"},{"key":"305","doi-asserted-by":"crossref","unstructured":"305. \u3000Nagai S, Yokomatsu T, Tanizawa K, et al. Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions. Intern Med<\/i> 2014; 53: 2761. PMID: 25447669","DOI":"10.2169\/internalmedicine.53.3120"},{"key":"306","unstructured":"306. \u3000Rossman MD, Newman LS, Baughman RP, et al. A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis<\/i> 2006; 23: 201\u2013208. PMID: 18038919"},{"key":"307","doi-asserted-by":"crossref","unstructured":"307. \u3000Uthman I, Touma Z, Khoury M. Cardiac sarcoidosis responding to monotherapy with infliximab. Clin Rheumatol<\/i> 2007; 26: 2001\u20132003. PMID: 17394036","DOI":"10.1007\/s10067-007-0614-1"},{"key":"308","unstructured":"308. \u3000Barnabe C, McMeekin J, Howarth A, et al. Successful treatment of cardiac sarcoidosis with infliximab. J Rheumatol<\/i> 2008; 35: 1686\u20131687. PMID: 18671332"},{"key":"309","unstructured":"309. \u3000The Japanese Circulation Society. Guidelines for treatment of chronic heart failure (JCS 2010). http:\/\/www.j-circ.or.jp\/guideline\/pdf\/JCS2010_matsuzaki_h.pdf [In Japanese]"},{"key":"310","unstructured":"310. \u3000The Japanese Circulation Society. Guidelines for treatment of chronic heart failure (JCS 2011). http:\/\/www.j-circ.or.jp\/guideline\/pdf\/JCS2011_izumi_h.pdf [In Japanese]"},{"key":"311","doi-asserted-by":"crossref","unstructured":"311. \u3000Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF\/AHA guideline for the management of heart failure: Executive summary: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation<\/i> 2013; 128: 1810\u20131852. PMID: 23741057","DOI":"10.1161\/CIR.0b013e31829e8807"},{"key":"312","doi-asserted-by":"crossref","unstructured":"312. \u3000Terasaki F, Ishizaka N. Cardiac sarcoidosis and arrhythmogenic right ventricular cardiomyopathy: Potential differential diagnoses for arrhythmogenic ventricular cardiomyopathy. Intern Med<\/i> 2016; 55: 1041\u20131042. PMID: 27150851","DOI":"10.2169\/internalmedicine.55.6422"},{"key":"313","doi-asserted-by":"crossref","unstructured":"313. \u3000Yodogawa K, Seino Y, Shiomura R, et al. Recovery of atrioventricular block following steroid therapy in patients with cardiac sarcoidosis. J Cardiol<\/i> 2013; 62: 320\u2013325. PMID: 24016620","DOI":"10.1016\/j.jjcc.2013.07.007"},{"key":"314","doi-asserted-by":"crossref","unstructured":"314. \u3000Tokuda M, Tedrow UB, Kojodjojo P, et al. Catheter ablation of ventricular tachycardia in nonischemic heart disease. Circ Arrhythm Electrophysiol<\/i> 2012; 5: 992\u20131000. PMID: 22942218","DOI":"10.1161\/CIRCEP.112.971341"},{"key":"315","doi-asserted-by":"crossref","unstructured":"315. \u3000Kusano KF, Satomi K. Diagnosis and treatment of cardiac sarcoidosis. Heart<\/i> 2016; 102: 184\u2013190. PMID: 26643814","DOI":"10.1136\/heartjnl-2015-307877"},{"key":"316","doi-asserted-by":"crossref","unstructured":"316. \u3000Noda T, Suyama K, Shimizu W, et al. Ventricular tachycardia with figure eight pattern originating from the right ventricle in a patient with cardiac sarcoidosis. Pacing Clin Electrophysiol<\/i> 2004; 27: 561\u2013562. PMID: 15078419","DOI":"10.1111\/j.1540-8159.2004.00485.x"},{"key":"317","doi-asserted-by":"crossref","unstructured":"317. \u3000Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med<\/i> 1991; 324: 781\u2013788. PMID: 1900101","DOI":"10.1056\/NEJM199103213241201"},{"key":"318","doi-asserted-by":"crossref","unstructured":"318. \u3000Yodogawa K, Seino Y, Ohara T, et al. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol<\/i> 2011; 16: 140\u2013147. PMID: 21496164","DOI":"10.1111\/j.1542-474X.2011.00418.x"},{"key":"319","unstructured":"319. \u3000The Japanese Circulation Society. Guidelines for non-pharmacotherapy of cardiac arrhythmias (JCS 2011). http:\/\/www.j-circ.or.jp\/guideline\/pdf\/JCS2011_okumura_h.pdf [In Japanese]"},{"key":"320","doi-asserted-by":"crossref","unstructured":"320. \u3000JCS Joint Working Group. Guidelines for non-pharmacotherapy of cardiac arrhythmias (JCS 2011): Digest version. Circ J<\/i> 2013; 77: 249\u2013274. PMID: 23165786","DOI":"10.1253\/circj.CJ-66-0054"},{"key":"321","doi-asserted-by":"crossref","unstructured":"321. \u3000Curtis AB, Worley SJ, Adamson PB, et al. Biventricular versus Right Ventricular Pacing in Heart Failure Patients with Atrioventricular Block (BLOCK HF) Trial Investigators. Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med<\/i> 2013; 368: 1585\u20131593. PMID: 23614585","DOI":"10.1056\/NEJMoa1210356"},{"key":"322","doi-asserted-by":"crossref","unstructured":"322. \u3000Sadek MM, Yung D, Birnie DH, et al. Corticosteroid therapy for cardiac sarcoidosis: A systematic review. Can J Cardiol<\/i> 2013; 29: 1034\u20131041. PMID: 23623644","DOI":"10.1016\/j.cjca.2013.02.004"},{"key":"323","doi-asserted-by":"crossref","unstructured":"323. \u3000Takaya Y, Kusano KF, Nakamura K, et al. Outcomes in patients with high-degree atrioventricular block as the initial manifestation of cardiac sarcoidosis. Am J Cardiol<\/i> 2015; 115: 505\u2013509. PMID: 25529542","DOI":"10.1016\/j.amjcard.2014.11.028"},{"key":"324","doi-asserted-by":"crossref","unstructured":"324. \u3000Sekiguchi M, Hiroe M, Take M, et al. Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. II. Myocarditis. Jpn Circ J<\/i> 1980; 44: 264\u2013273. PMID: 6154812","DOI":"10.1253\/jcj.44.264"},{"key":"325","doi-asserted-by":"crossref","unstructured":"325. \u3000Betensky BP, Tschabrunn CM, Zado ES, et al. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators. Heart Rhythm<\/i> 2012; 9: 884\u2013891. PMID: 22338670","DOI":"10.1016\/j.hrthm.2012.02.010"},{"key":"326","doi-asserted-by":"crossref","unstructured":"326. \u3000Kron J, Sauer W, Schuller J, et al. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace<\/i> 2013; 15: 347\u2013354. PMID: 23002195","DOI":"10.1093\/europace\/eus316"},{"key":"327","doi-asserted-by":"crossref","unstructured":"327. \u3000Schuller JL, Zipse M, Crawford T, et al. Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis. J Cardiovasc Electrophysiol<\/i> 2012; 23: 925\u2013929. PMID: 22812589","DOI":"10.1111\/j.1540-8167.2012.02350.x"},{"key":"328","unstructured":"328. \u3000Epstein AE, DiMarco JP, Ellenbogen KA, et al. American College of Cardiology Foundation, American Heart Association Task Force on Practice Guidelines, Heart Rhythm Society. 2012 ACCF\/AHA\/HRS focused update incorporated into the ACCF\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation<\/i> 2013; 127: e283\u2013e352. PMID: 23255456"},{"key":"329","unstructured":"329. \u3000Epstein AE, Dimarco JP, Ellenbogen KA, et al. American College of Cardiology\/American Heart Association Task Force on Practice, American Association for Thoracic Surgery, Society of Thoracic Surgeons. ACC\/AHA\/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive summary. Heart Rhythm<\/i> 2008; 5: 934\u2013955. PMID: 18534377"},{"key":"330","doi-asserted-by":"crossref","unstructured":"330. \u3000Crawford T, Mueller G, Sarsam S, et al. Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias. Circ Arrhythm Electrophysiol<\/i> 2014; 7: 1109\u20131115. PMID: 25266311","DOI":"10.1161\/CIRCEP.113.000156"},{"key":"331","doi-asserted-by":"crossref","unstructured":"331. \u3000Abraham WT, Fisher WG, Smith AL, et al. MIRACLE Study Group. Cardiac resynchronization in chronic heart failure. N Engl J Med<\/i> 2002; 346: 1845\u20131853. PMID: 12063368","DOI":"10.1056\/NEJMoa013168"},{"key":"332","doi-asserted-by":"crossref","unstructured":"332. \u3000Bristow MR, Saxon LA, Boehmer J, et al. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med<\/i> 2004; 350: 2140\u20132150. PMID: 15152059","DOI":"10.1056\/NEJMoa032423"},{"key":"333","doi-asserted-by":"crossref","unstructured":"333. \u3000Cleland JG, Daubert JC, Erdmann E, et al. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med<\/i> 2005; 352: 1539\u20131549. PMID: 15753115","DOI":"10.1056\/NEJMoa050496"},{"key":"334","doi-asserted-by":"crossref","unstructured":"334. \u3000Stees CS, Khoo MS, Lowery CM, et al. Ventricular tachycardia storm successfully treated with immunosuppression and catheter ablation in a patient with cardiac sarcoidosis. J Cardiovasc Electrophysiol<\/i> 2011; 22: 210\u2013213. PMID: 20561106","DOI":"10.1111\/j.1540-8167.2010.01826.x"},{"key":"335","doi-asserted-by":"crossref","unstructured":"335. \u3000Jefic D, Joel B, Good E, et al. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: Report from a multicenter registry. Heart Rhythm<\/i> 2009; 6: 189\u2013195. PMID: 19187909","DOI":"10.1016\/j.hrthm.2008.10.039"},{"key":"336","doi-asserted-by":"crossref","unstructured":"336. \u3000Dechering DG, Kochh\u00e4user S, Wasmer K, et al. Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm<\/i> 2013; 10: 158\u2013164. PMID: 23070261","DOI":"10.1016\/j.hrthm.2012.10.019"},{"key":"337","doi-asserted-by":"crossref","unstructured":"337. \u3000Daimon M, Sasaki T, Woo E, et al. Successful surgical treatment for dilated cardiomyopathy with cardiac sarcoidosis. Ann Thorac Surg<\/i> 2007; 84: e12\u2013e13. PMID: 17643597","DOI":"10.1016\/j.athoracsur.2007.04.044"},{"key":"338","doi-asserted-by":"crossref","unstructured":"338. \u3000Shimamoto T, Nishina T, Marui A, et al. Dual left ventricular restorations in a patient with cardiac sarcoidosis. J Thorac Cardiovasc Surg<\/i> 2009; 137: 1286\u20131288. PMID: 19380011","DOI":"10.1016\/j.jtcvs.2008.04.007"},{"key":"339","doi-asserted-by":"crossref","unstructured":"339. \u3000Hirota M, Yoshida M, Hoshino J, et al. Sublocalization of cardiac involvement in sarcoidosis and surgical exclusion in patients with congestive heart failure. Ann Thorac Surg<\/i> 2015; 100: 81\u201387. PMID: 25986102","DOI":"10.1016\/j.athoracsur.2015.02.043"},{"key":"340","doi-asserted-by":"crossref","unstructured":"340. \u3000Perkel D, Czer LS, Morrissey RP, et al. Heart transplantation for endstage heart failure due to cardiac sarcoidosis. Transplant Proc<\/i> 2013; 45: 2384\u20132386. PMID: 23953552","DOI":"10.1016\/j.transproceed.2013.02.116"},{"key":"341","doi-asserted-by":"crossref","unstructured":"341. \u3000Zaidi AR, Zaidi A, Vaitkus PT. Outcome of heart transplantation in patients with sarcoid cardiomyopathy. J Heart Lung Transplant<\/i> 2007; 26: 714\u2013717. PMID: 17613402","DOI":"10.1016\/j.healun.2007.05.006"},{"key":"342","doi-asserted-by":"crossref","unstructured":"342. \u3000Akashi H, Kato TS, Takayama H, et al. Outcome of patients with cardiac sarcoidosis undergoing cardiac transplantation: Single-center retrospective analysis. J Cardiol<\/i> 2012; 60: 407\u2013410. PMID: 22890069","DOI":"10.1016\/j.jjcc.2012.07.013"},{"key":"343","doi-asserted-by":"crossref","unstructured":"343. \u3000Yager JE, Hernandez AF, Steenbergen C, et al. Recurrence of cardiac sarcoidosis in a heart transplant recipient. J Heart Lung Transplant<\/i> 2005; 24: 1988\u20131990. PMID: 16297811","DOI":"10.1016\/j.healun.2005.02.016"},{"key":"344","unstructured":"344. \u3000Milman N, Andersen CB, Mortensen SA, et al. Cardiac sarcoidosis and heart transplantation: A report of four consecutive patients. Sarcoidosis Vasc Diffuse Lung Dis<\/i> 2008; 25: 51\u201359. PMID: 19070261"},{"key":"345","unstructured":"345. \u3000Meeting materials for the Heart Transplantation Committee of the Japanese Circulation Society. [In Japanese]"},{"key":"346","unstructured":"346. \u3000The Heart Transplantation Committee of the Japanese Circulation Society. Criteria for heart transplant recipients. http:\/\/www.j-circ.or.jp\/hearttp\/HTRecCriteria.html [In Japanese]"},{"key":"347","unstructured":"347. \u3000INTERMACS website. http:\/\/www.uab.edu\/medicine\/intermacs\/ [In Japanese]"},{"key":"348","unstructured":"348. \u3000The Pharmaceuticals and Medical Devices Agency. Development of data collection and evaluation systems on the use of mobile medical device tracking. http:\/\/www.pmda.go.jp\/safety\/surveillance-analysis\/0009.html [In Japanese]"},{"key":"349","unstructured":"349. \u3000The Japanese Circulation Society, the Japanese Society for Cardiovascular Surgery. Guidelines for device therapy: Implantable left ventricular assist device for patients with severe heart failure (JCS\/JSCVS2013). http:\/\/www.j-circ.or.jp\/guideline\/pdf\/JCS2013_kyo_h.pdf [In Japanese]"},{"key":"350","unstructured":"350. \u3000The Japanese Association for Clinical Ventricular Assist Systems. Practice standard for the use of ventricular assist devices (Draft published on November 16, 2010). http:\/\/www.jacvas.com\/application\/2\/standard\/ [In Japanese]"},{"key":"351","doi-asserted-by":"crossref","unstructured":"351. \u3000Roberts WC, Vowels TJ, Ko JM, et al. Cardiac transplantation for cardiac sarcoidosis with initial diagnosis by examination of the left ventricular apical \u201ccore\u201d excised for insertion of a left ventricular assist device for severe chronic heart failure. Am J Cardiol<\/i> 2009; 103: 110\u2013114. PMID: 19101239","DOI":"10.1016\/j.amjcard.2008.08.053"},{"key":"352","doi-asserted-by":"crossref","unstructured":"352. \u3000DePasquale EC, Nasir K, Jacoby DL. Outcomes of adults with restrictive cardiomyopathy after heart transplantation. J Heart Lung Transplant<\/i> 2012; 31: 1269\u20131275. PMID: 23079066","DOI":"10.1016\/j.healun.2012.09.018"},{"key":"353","doi-asserted-by":"crossref","unstructured":"353. \u3000Chang TI, Chi NH, Chou NK, et al. Isolated cardiac sarcoidosis in heart transplantation. Transplant Proc<\/i> 2012; 44: 903\u2013906. PMID: 22564580","DOI":"10.1016\/j.transproceed.2012.01.087"},{"key":"354","doi-asserted-by":"crossref","unstructured":"354. \u3000Eishi Y. Etiology of sarcoidosis-in relation to infection, especiallyPropionibacterium acnes. Propionibacterium acnes. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders<\/i> 2011; 31: 81\u201383. [In Japanese]","DOI":"10.7878\/jjsogd.31.81"},{"key":"355","doi-asserted-by":"crossref","unstructured":"355. \u3000Eishi Y. Pathogenesis of cardiac sarcoidosis according to an etiologic hypothesis as caused byPropionibacterium acnes. Propionibacterium acnes. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders<\/i> 2010; 30: 86\u201388. [In Japanese]","DOI":"10.7878\/jjsogd.30.86"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/11\/83_CJ-19-0508\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T07:49:09Z","timestamp":1695282549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/11\/83_CJ-19-0508\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":355,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-19-0508","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,25]]}}}